{ "instance": { "emma-10ka_20201231.htm": { "axisCustom": 0, "axisStandard": 36, "contextCount": 387, "dts": { "calculationLink": { "local": [ "emma-20201231_cal.xml" ] }, "definitionLink": { "local": [ "emma-20201231_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "emma-10ka_20201231.htm" ] }, "labelLink": { "local": [ "emma-20201231_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "emma-20201231_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "emma-20201231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 744, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 50, "http://www.emmausmedical.com/20201231": 6, "http://xbrl.sec.gov/dei/2020-01-31": 4, "total": 60 }, "keyCustom": 98, "keyStandard": 414, "memberCustom": 93, "memberStandard": 42, "nsprefix": "emma", "nsuri": "http://www.emmausmedical.com/20201231", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100090 - Disclosure - SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETS", "shortName": "SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100100 - Disclosure - INVESTMENTS", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTS", "shortName": "INVESTMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100110 - Disclosure - SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIES", "shortName": "SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - NOTES PAYABLE", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLE", "shortName": "NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - STOCKHOLDERS' DEFICIT", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICIT", "shortName": "STOCKHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100140 - Disclosure - INCOME TAXES", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXES", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100150 - Disclosure - LEASES", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASES", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100160 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DefinedContributionPlanTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - DEFINED CONTRIBUTION PLAN", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDEFINEDCONTRIBUTIONPLAN", "shortName": "DEFINED CONTRIBUTION PLAN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DefinedContributionPlanTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - SUBSEQUENT EVENTS", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTS", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - REVENUES (Tables)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESTables", "shortName": "REVENUES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100220 - Disclosure - SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS (Tables)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSTables", "shortName": "SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100230 - Disclosure - INVESTMENTS (Tables)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSTables", "shortName": "INVESTMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100240 - Disclosure - SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Tables)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESTables", "shortName": "SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - NOTES PAYABLE (Tables)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables", "shortName": "NOTES PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100260 - Disclosure - STOCKHOLDERS' DEFICIT (Tables)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITTables", "shortName": "STOCKHOLDERS' DEFICIT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - INCOME TAXES (Tables)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - LEASES (Tables)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSTables", "shortName": "RELATED PARTY TRANSACTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - SUBSEQUENT EVENTS (Tables)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSTables", "shortName": "SUBSEQUENT EVENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_srtStatementGeographicalAxis_us-gaapEuropeanUnionMember_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "emma:OrphanDrugDesignationProvidesAdditionalMarketingExclusivityPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100310 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative", "shortName": "DESCRIPTION OF BUSINESS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_srtStatementGeographicalAxis_us-gaapEuropeanUnionMember_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "emma:OrphanDrugDesignationProvidesAdditionalMarketingExclusivityPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:InventoryPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "INF", "lang": null, "name": "emma:NumberOfVendors", "reportCount": 1, "unique": true, "unitRef": "U_emmaVendor", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100330 - Disclosure - REVENUES (Details)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails", "shortName": "REVENUES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_srtProductOrServiceAxis_emmaEndariMember_20200101_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "emma:RevenueAllowanceAndAccrualActivitiesTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20191231", "decimals": "-3", "first": true, "lang": null, "name": "emma:RevenueAllowanceAndAccrualActivities", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100340 - Disclosure - REVENUES (Details 1)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails1", "shortName": "REVENUES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "emma:RevenueAllowanceAndAccrualActivitiesTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20181231", "decimals": "-3", "lang": null, "name": "emma:RevenueAllowanceAndAccrualActivities", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_srtMajorCustomersAxis_emmaCustomerOneMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100350 - Disclosure - REVENUES (Details 2)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails2", "shortName": "REVENUES (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_srtMajorCustomersAxis_emmaCustomerOneMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100360 - Disclosure - REVENUES (Details Narrative)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetailsNarrative", "shortName": "REVENUES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_srtCounterpartyNameAxis_emmaTelconIncMember_20200101_20201231", "decimals": "-6", "lang": null, "name": "emma:UpfrontPayment", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSupplies", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100370 - Disclosure - SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS (Details)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails", "shortName": "SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSupplies", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherAssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100380 - Disclosure - SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS (Details 1)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails1", "shortName": "SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherAssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100390 - Disclosure - SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS (Details 2)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails2", "shortName": "SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100400 - Disclosure - SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS (Details Narrative)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetailsNarrative", "shortName": "SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100410 - Disclosure - INVESTMENTS (Details Narrative)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "shortName": "INVESTMENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200928_20200928", "decimals": null, "lang": "en-US", "name": "us-gaap:DebtInstrumentCallDateEarliest", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapInvestmentTypeAxis_emmaInvestmentInConvertibleBondsMember_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100420 - Disclosure - INVESTMENTS (Details)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails", "shortName": "INVESTMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapInvestmentTypeAxis_emmaInvestmentInConvertibleBondsMember_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200629", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100430 - Disclosure - INVESTMENTS (Details 1)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "shortName": "INVESTMENTS (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapMeasurementInputTypeAxis_emmaMeasurementInputSelectedYieldMember_us-gaapValuationTechniqueAxis_emmaValuationTechniqueBinomialMonteCarloCliquetOptionPricingModelMember_20200928", "decimals": "INF", "lang": null, "name": "us-gaap:AlternativeInvestmentMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100440 - Disclosure - INVESTMENTS (Details 2)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2", "shortName": "INVESTMENTS (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis_emmaEJHoldingsIncMember_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "emma:CROExpenses", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100450 - Disclosure - SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails", "shortName": "SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "emma:CROExpenses", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherLiabilitiesNoncurrent", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100460 - Disclosure - SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details 1)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails1", "shortName": "SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapBalanceSheetLocationAxis_us-gaapOtherNoncurrentLiabilitiesMember_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:OtherLiabilitiesNoncurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_srtCounterpartyNameAxis_emmaTelconIncMember_us-gaapTypeOfArrangementAxis_emmaAPISupplyAgreementMember_20170611_20170612", "decimals": "-5", "first": true, "lang": null, "name": "emma:ProceedsFromSupplyAgreement", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100470 - Disclosure - SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details Narrative)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative", "shortName": "SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_srtCounterpartyNameAxis_emmaTelconIncMember_us-gaapTypeOfArrangementAxis_emmaAPISupplyAgreementMember_20170611_20170612", "decimals": "-5", "first": true, "lang": null, "name": "emma:ProceedsFromSupplyAgreement", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200228", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100480 - Disclosure - NOTES PAYABLE (Details)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "shortName": "NOTES PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapDebtInstrumentAxis_emmaNotesPayableOtherPayables2013Member_20201231", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20181231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20181231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200228", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100490 - Disclosure - NOTES PAYABLE (Details 1)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "shortName": "NOTES PAYABLE (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapDebtInstrumentAxis_emmaConvertibleDebentures2019Member_20201231", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200228", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100500 - Disclosure - NOTES PAYABLE (Details 2)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "shortName": "NOTES PAYABLE (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapDebtInstrumentAxis_emmaConvertibleNotesPayable2018Member_20201231", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DebtWeightedAverageInterestRate", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100510 - Disclosure - NOTES PAYABLE (Details Narrative)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative", "shortName": "NOTES PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DebtWeightedAverageInterestRate", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100520 - Disclosure - NOTES PAYABLE (Details 3)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails3", "shortName": "NOTES PAYABLE (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapBalanceSheetLocationAxis_us-gaapOtherCurrentLiabilitiesMember_us-gaapDebtInstrumentAxis_emmaAmendedAndRestatedTenPercentageOfSeniorSecuredDebenturesMember_us-gaapFairValueByLiabilityClassAxis_emmaConversionFeatureLiabilitiesMember_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100530 - Disclosure - NOTES PAYABLE (Details 4)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4", "shortName": "NOTES PAYABLE (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapBalanceSheetLocationAxis_us-gaapOtherCurrentLiabilitiesMember_us-gaapDebtInstrumentAxis_emmaAmendedAndRestatedTenPercentageOfSeniorSecuredDebenturesMember_us-gaapFairValueByLiabilityClassAxis_emmaConversionFeatureLiabilitiesMember_20190101_20191231", "decimals": "-3", "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200629", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100540 - Disclosure - NOTES PAYABLE (Details 5)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5", "shortName": "NOTES PAYABLE (Details 5)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapMeasurementInputTypeAxis_emmaMeasurementInputSelectedYieldMember_us-gaapValuationTechniqueAxis_emmaValuationTechniqueBinomialMonteCarloCliquetOptionPricingModelMember_20200221", "decimals": "INF", "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100550 - Disclosure - STOCKHOLDERS' DEFICIT (Details Narrative)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "shortName": "STOCKHOLDERS' DEFICIT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200228", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_srtCounterpartyNameAxis_emmaGPBDebtHoldingsIILLCMember_us-gaapFairValueByLiabilityClassAxis_emmaLiabilityInstrumentWarrantsMember_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100560 - Disclosure - STOCKHOLDERS' DEFICIT (Details)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails", "shortName": "STOCKHOLDERS' DEFICIT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_srtCounterpartyNameAxis_emmaGPBDebtHoldingsIILLCMember_us-gaapFairValueByLiabilityClassAxis_emmaLiabilityInstrumentWarrantsMember_20181231", "decimals": "-3", "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200629", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100570 - Disclosure - STOCKHOLDERS' DEFICIT (Details 1)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "shortName": "STOCKHOLDERS' DEFICIT (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_srtCounterpartyNameAxis_emmaGPBDebtHoldingsIILLCMember_20201231", "decimals": "INF", "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapDebtInstrumentAxis_emmaTenPercentageOfSeniorSecuredConvertibleDebenturesMember_us-gaapFairValueByLiabilityClassAxis_emmaLiabilityInstrumentWarrantsMember_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100580 - Disclosure - STOCKHOLDERS' DEFICIT (Details 2)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails2", "shortName": "STOCKHOLDERS' DEFICIT (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapDebtInstrumentAxis_emmaTenPercentageOfSeniorSecuredConvertibleDebenturesMember_us-gaapFairValueByLiabilityClassAxis_emmaLiabilityInstrumentWarrantsMember_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200629", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100590 - Disclosure - STOCKHOLDERS' DEFICIT (Details 3)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3", "shortName": "STOCKHOLDERS' DEFICIT (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapDebtInstrumentAxis_emmaConvertiblePromissoryNoteMember_20201231", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100600 - Disclosure - STOCKHOLDERS' DEFICIT (Details 4)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails4", "shortName": "STOCKHOLDERS' DEFICIT (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapClassOfWarrantOrRightAxis_us-gaapWarrantMember_20181231", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100610 - Disclosure - STOCKHOLDERS' DEFICIT (Details 5)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5", "shortName": "STOCKHOLDERS' DEFICIT (Details 5)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "INF", "lang": null, "name": "emma:WarrantsExercisable", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200629", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100620 - Disclosure - STOCKHOLDERS' DEFICIT (Details 6)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6", "shortName": "STOCKHOLDERS' DEFICIT (Details 6)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200629", "decimals": "2", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapPlanNameAxis_emmaSTIP2011PlanMember_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100630 - Disclosure - STOCKHOLDERS' DEFICIT (Details 7)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7", "shortName": "STOCKHOLDERS' DEFICIT (Details 7)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapPlanNameAxis_emmaSTIP2011PlanMember_20181231", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100640 - Disclosure - INCOME TAXES (Details)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails", "shortName": "INCOME TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100650 - Disclosure - INCOME TAXES (Details 1)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1", "shortName": "INCOME TAXES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "emma:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionLossAndOthers", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100660 - Disclosure - INCOME TAXES (Details 2)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails2", "shortName": "INCOME TAXES (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "emma:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionLossAndOthers", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100670 - Disclosure - INCOME TAXES (Details Narrative)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100680 - Disclosure - INCOME TAXES (Details 3)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3", "shortName": "INCOME TAXES (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100060 - Disclosure - DESCRIPTION OF BUSINESS", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESS", "shortName": "DESCRIPTION OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100690 - Disclosure - LEASES (Details Narrative)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative", "shortName": "LEASES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100700 - Disclosure - LEASES (Details)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails", "shortName": "LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_srtCounterpartyNameAxis_emmaTelconRFPharmaceuticalsIncMember_us-gaapTypeOfArrangementAxis_emmaAPISupplyAgreementMember_20170611_20170612", "decimals": "-5", "first": true, "lang": null, "name": "emma:ProceedsFromSupplyAgreement", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100720 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_srtCounterpartyNameAxis_emmaTelconRFPharmaceuticalsIncMember_us-gaapTypeOfArrangementAxis_emmaAPISupplyAgreementMember_20170611_20170612", "decimals": "-5", "first": true, "lang": null, "name": "emma:ProceedsFromSupplyAgreement", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100730 - Disclosure - RELATED PARTY TRANSACTIONS (Details)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails", "shortName": "RELATED PARTY TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapDebtInstrumentAxis_emmaPromissoryNotePayableAndConvertibleNotesPayableToRelatedParties24Member_20201231", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20191231", "decimals": "INF", "first": true, "lang": null, "name": "emma:MarketableSecuritiesCommonStockOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100740 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20191231", "decimals": "INF", "first": true, "lang": null, "name": "emma:MarketableSecuritiesCommonStockOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "p", "us-gaap:DefinedContributionPlanTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100750 - Disclosure - DEFINED CONTRIBUTION PLAN (Details Narrative)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDEFINEDCONTRIBUTIONPLANDetailsNarrative", "shortName": "DEFINED CONTRIBUTION PLAN (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DefinedContributionPlanTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100760 - Disclosure - SUBSEQUENT EVENTS (Details)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetails", "shortName": "SUBSEQUENT EVENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfSubsequentEventsTextBlock", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210101_20210101", "decimals": "-3", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200228", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100770 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_us-gaapLongtermDebtTypeAxis_emmaSeniorSecuredDebenturesMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_emmaSecuritiesPurchaseAgreementMember_20210101_20210331", "decimals": "-5", "lang": null, "name": "emma:ConvertiblePromissoryNotesAmountUsedToPrepayOutstandingOfDebentures", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100070 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100080 - Disclosure - REVENUES", "role": "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUES", "shortName": "REVENUES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "emma-10ka_20201231.htm", "contextRef": "C_0000822370_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 139, "tag": { "country_AE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED ARAB EMIRATES", "terseLabel": "Dubai, United Arab Emirates [Member]" } } }, "localname": "AE", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "domainItemType" }, "country_JP": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "JAPAN", "terseLabel": "Tokyo, Japan [Member]" } } }, "localname": "JP", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "US [Member]" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description", "terseLabel": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r566", "r567", "r568" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "verboseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r569" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line2", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "verboseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r572" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "verboseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity a Voluntary Filer" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well Known Seasoned Issuer", "terseLabel": "Entity a Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r566", "r567", "r568" ], "lang": { "en-us": { "role": { "label": "Icfr Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "emma_APISupplyAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.", "label": "A P I Supply Agreement [Member]", "terseLabel": "API Supply Agreement [Member]" } } }, "localname": "APISupplyAgreementMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_AccountsPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts payable", "label": "Accounts Payable [Abstract]", "terseLabel": "Accounts payable:" } } }, "localname": "AccountsPayableAbstract", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "stringItemType" }, "emma_AccruedGovernmentRebatesAndOtherRebatesCurrent": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails": { "order": 10060.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued government rebates and other rebates current.", "label": "Accrued Government Rebates And Other Rebates Current", "terseLabel": "Government rebates and other rebates" } } }, "localname": "AccruedGovernmentRebatesAndOtherRebatesCurrent", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "emma_AccruedManufacturingExpensesCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued manufacturing expenses current.", "label": "Accrued Manufacturing Expenses Current", "terseLabel": "Manufacturing cost" } } }, "localname": "AccruedManufacturingExpensesCurrent", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "emma_AdjustmentOfMergerExchangeRatioMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Adjustment of merger exchange ratio.", "label": "Adjustment Of Merger Exchange Ratio [Member]", "terseLabel": "Adjustment of Merger Exchange Ratio [Member]" } } }, "localname": "AdjustmentOfMergerExchangeRatioMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_AdjustmentsToFairValueOfReplacementEquityAwards": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to fair value of replacement equity awards.", "label": "Adjustments To Fair Value Of Replacement Equity Awards", "terseLabel": "Fair value of replacement equity awards" } } }, "localname": "AdjustmentsToFairValueOfReplacementEquityAwards", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "monetaryItemType" }, "emma_AgreementTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period term of agreement term.", "label": "Agreement Term", "terseLabel": "Agreement term" } } }, "localname": "AgreementTerm", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative" ], "xbrltype": "durationItemType" }, "emma_AlternativeInvestmentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alternative investment term.", "label": "Alternative Investment Term", "terseLabel": "Expected life (in years)" } } }, "localname": "AlternativeInvestmentTerm", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1" ], "xbrltype": "durationItemType" }, "emma_AmendedAndRestatedDebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended and restated debentures.", "label": "Amended And Restated Debentures [Member]", "terseLabel": "Amended and Restated Debentures [Member]" } } }, "localname": "AmendedAndRestatedDebenturesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_AmendedAndRestatedTenPercentageOfSeniorSecuredDebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended and restated ten percentage of senior secured debentures.", "label": "Amended And Restated Ten Percentage Of Senior Secured Debentures [Member]", "terseLabel": "Amended And Restated Ten Percentage Of Senior Secured Debentures", "verboseLabel": "Amended and Restated 10% Senior Secured Debentures [Member]" } } }, "localname": "AmendedAndRestatedTenPercentageOfSeniorSecuredDebenturesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4" ], "xbrltype": "domainItemType" }, "emma_AmendedAndRestatedWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended and restated warrants.", "label": "Amended And Restated Warrants [Member]", "terseLabel": "Amended and Restated Warrants [Member]" } } }, "localname": "AmendedAndRestatedWarrantsMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_BeneficialConversionFeaturesOfConvertibleNotesPayablePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Beneficial conversion features of convertible notes payable.", "label": "Beneficial Conversion Features Of Convertible Notes Payable Policy [Text Block]", "terseLabel": "Beneficial conversion features of convertible notes payable" } } }, "localname": "BeneficialConversionFeaturesOfConvertibleNotesPayablePolicyTextBlock", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "emma_BusinessCreditsCarryforwardsExpirationYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration year of general business tax credits included in operating loss carryforward, in CCYY format.", "label": "Business Credits Carryforwards Expiration Year", "terseLabel": "Business credits expiration year" } } }, "localname": "BusinessCreditsCarryforwardsExpirationYear", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetailsNarrative" ], "xbrltype": "gYearItemType" }, "emma_CROExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value of payables relating to a Contract Research Organization.", "label": "C R O Expenses", "terseLabel": "Clinical and regulatory expenses" } } }, "localname": "CROExpenses", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "emma_ClassOfWarrantOrRightOutstanding1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding used for option pricing model.", "label": "Class Of Warrant Or Right Outstanding1", "verboseLabel": "Number outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding1", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1" ], "xbrltype": "sharesItemType" }, "emma_ConversionFeatureLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion feature liabilities.", "label": "Conversion Feature Liabilities [Member]", "terseLabel": "Conversion Feature Liabilities [Member]" } } }, "localname": "ConversionFeatureLiabilitiesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables" ], "xbrltype": "domainItemType" }, "emma_ConversionOfAccruedInterestPayableToCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represents conversion of accrued interest payable to common stock.", "label": "Conversion Of Accrued Interest Payable To Common Stock", "terseLabel": "Conversion of accrued interest payable to common stock" } } }, "localname": "ConversionOfAccruedInterestPayableToCommonStock", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "emma_ConvertibleBondInitialConversionPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible bond initial conversion price.", "label": "Convertible Bond Initial Conversion Price", "terseLabel": "Convertible bond initial conversion price" } } }, "localname": "ConvertibleBondInitialConversionPrice", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "perShareItemType" }, "emma_ConvertibleBondMaturityDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible bond maturity date.", "label": "Convertible Bond Maturity Date", "terseLabel": "Convertible bond maturity date" } } }, "localname": "ConvertibleBondMaturityDate", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetailsNarrative" ], "xbrltype": "dateItemType" }, "emma_ConvertibleBondMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible bond.", "label": "Convertible Bond [Member]", "terseLabel": "10-year Convertible Bond [Member]" } } }, "localname": "ConvertibleBondMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_ConvertibleBondPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible bond purchase agreement.", "label": "Convertible Bond Purchase Agreement [Member]", "terseLabel": "Convertible Bond Purchase Agreement [Member]" } } }, "localname": "ConvertibleBondPurchaseAgreementMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_ConvertibleDebentures2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible debentures 2019.", "label": "Convertible Debentures2019 [Member]", "terseLabel": "2019 Convertible Debentures [Member]" } } }, "localname": "ConvertibleDebentures2019Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1" ], "xbrltype": "domainItemType" }, "emma_ConvertibleDebenturesConversionPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible debentures conversion price.", "label": "Convertible Debentures Conversion Price", "verboseLabel": "Conversion debentures price" } } }, "localname": "ConvertibleDebenturesConversionPrice", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "perShareItemType" }, "emma_ConvertibleDebenturesCurrent": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible debentures current.", "label": "Convertible Debentures Current", "totalLabel": "Convertible Debentures, Current" } } }, "localname": "ConvertibleDebenturesCurrent", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1" ], "xbrltype": "monetaryItemType" }, "emma_ConvertibleDebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible debentures.", "label": "Convertible Debentures [Member]", "terseLabel": "Convertible Debentures [Member]" } } }, "localname": "ConvertibleDebenturesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1" ], "xbrltype": "domainItemType" }, "emma_ConvertibleNotesPayable2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents convertible notes payable.", "label": "Convertible Notes Payable2018 [Member]", "terseLabel": "2018 Convertible Notes Payable [Member]" } } }, "localname": "ConvertibleNotesPayable2018Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2" ], "xbrltype": "domainItemType" }, "emma_ConvertibleNotesPayableToRelatedPartiesNonCurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible notes payable to related parties non current.", "label": "Convertible Notes Payable To Related Parties Non Current [Member]", "terseLabel": "Convertible notes payable - related party non-current [Member]" } } }, "localname": "ConvertibleNotesPayableToRelatedPartiesNonCurrentMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_ConvertiblePromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible promissory note.", "label": "Convertible Promissory Note [Member]", "terseLabel": "Convertible Promissory Note [Member]", "verboseLabel": "Convertible Promissory Note [Member]" } } }, "localname": "ConvertiblePromissoryNoteMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_ConvertiblePromissoryNotesAmountUsedToPrepayOutstandingOfDebentures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Convertible Promissory Notes Amount Used To Prepay Outstanding Of Debentures", "terseLabel": "Convertible promissory notes amount used to prepay outstanding" } } }, "localname": "ConvertiblePromissoryNotesAmountUsedToPrepayOutstandingOfDebentures", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "emma_ConvertiblePromissoryNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible promissory notes.", "label": "Convertible Promissory Notes [Member]", "terseLabel": "Convertible Promissory Notes [Member]" } } }, "localname": "ConvertiblePromissoryNotesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer one.", "label": "Customer One [Member]", "terseLabel": "Customer A [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails2" ], "xbrltype": "domainItemType" }, "emma_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer two.", "label": "Customer Two [Member]", "terseLabel": "Customer B [Member]" } } }, "localname": "CustomerTwoMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails2" ], "xbrltype": "domainItemType" }, "emma_DebentureAndWarrantsIssuedToOriginalLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debenture and warrants issued to original loan.", "label": "Debenture And Warrants Issued To Original Loan", "terseLabel": "Debenture and warrants issued to original loan" } } }, "localname": "DebentureAndWarrantsIssuedToOriginalLoan", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "emma_DebenturesAndWarrantsIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debentures and warrants issued.", "label": "Debentures And Warrants Issued", "terseLabel": "Principal amount of debentures and warrants issued" } } }, "localname": "DebenturesAndWarrantsIssued", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "emma_DebtInstrumentConvertibleNumberOfEquityInstrumentsCurrent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The current portion number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.", "label": "Debt Instrument Convertible Number Of Equity Instruments Current", "terseLabel": "Shares Underlying Notes Current" } } }, "localname": "DebtInstrumentConvertibleNumberOfEquityInstrumentsCurrent", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1" ], "xbrltype": "integerItemType" }, "emma_DebtInstrumentConvertibleNumberOfEquityInstrumentsNonCurrent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The non current portion number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.", "label": "Debt Instrument Convertible Number Of Equity Instruments Non Current", "terseLabel": "Shares Underlying Notes Non Current" } } }, "localname": "DebtInstrumentConvertibleNumberOfEquityInstrumentsNonCurrent", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2" ], "xbrltype": "integerItemType" }, "emma_DebtInstrumentForgivenessDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument forgiveness description.", "label": "Debt Instrument Forgiveness Description", "terseLabel": "Debt instrument, forgiveness description" } } }, "localname": "DebtInstrumentForgivenessDescription", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "stringItemType" }, "emma_DebtInstrumentHighestPrincipalOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt before deduction of unamortized discount or premium. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, with initial maturities beyond one year or the normal operating cycle, if longer.", "label": "Debt Instrument Highest Principal Outstanding Amount", "terseLabel": "Highest Principal Outstanding" } } }, "localname": "DebtInstrumentHighestPrincipalOutstandingAmount", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "emma_DebtInstrumentPrepaymentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument prepayment description.", "label": "Debt Instrument Prepayment Description", "terseLabel": "Debt prepayment description" } } }, "localname": "DebtInstrumentPrepaymentDescription", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "stringItemType" }, "emma_DebtInstrumentPrincipalOutstandingAmount": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails": { "order": 10050.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt before deduction of unamortized discount or premium. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, with initial maturities beyond one year or the normal operating cycle, if longer.", "label": "Debt Instrument Principal Outstanding Amount", "terseLabel": "Principal Outstanding" } } }, "localname": "DebtInstrumentPrincipalOutstandingAmount", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2" ], "xbrltype": "monetaryItemType" }, "emma_DebtInstrumentPrincipalOutstandingCurrent": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails": { "order": 10030.0, "parentTag": "us-gaap_NotesPayableCurrent", "weight": 1.0 }, "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1": { "order": 10010.0, "parentTag": "emma_ConvertibleDebenturesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of current portion long-term debt before deduction of unamortized discount or premium. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, with initial maturities beyond one year or the normal operating cycle, if longer.", "label": "Debt Instrument Principal Outstanding Current", "terseLabel": "Principal Outstanding, Current" } } }, "localname": "DebtInstrumentPrincipalOutstandingCurrent", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1" ], "xbrltype": "monetaryItemType" }, "emma_DebtInstrumentPrincipalOutstandingNonCurrent": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails": { "order": 10010.0, "parentTag": "us-gaap_LongTermNotesPayable", "weight": 1.0 }, "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2": { "order": 10010.0, "parentTag": "us-gaap_ConvertibleLongTermNotesPayable", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of non current portion long-term debt before deduction of unamortized discount or premium. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, with initial maturities beyond one year or the normal operating cycle, if longer.", "label": "Debt Instrument Principal Outstanding Non Current", "terseLabel": "Principal Outstanding, Non Current" } } }, "localname": "DebtInstrumentPrincipalOutstandingNonCurrent", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2" ], "xbrltype": "monetaryItemType" }, "emma_DebtWeightedAverageEffectiveInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to average effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Weighted Average Effective Interest Rate", "terseLabel": "Average effective interest rate" } } }, "localname": "DebtWeightedAverageEffectiveInterestRate", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "percentItemType" }, "emma_DeferredTaxAssetsUnearnedRevenue": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1": { "order": 10080.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets unearned revenue.", "label": "Deferred Tax Assets Unearned Revenue", "terseLabel": "Unearned revenue" } } }, "localname": "DeferredTaxAssetsUnearnedRevenue", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1" ], "xbrltype": "monetaryItemType" }, "emma_DeferredTaxAssetsUnrealizedGainLossOnLongTermInvestment": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1": { "order": 10100.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets unrealized gain loss on long term investment.", "label": "Deferred Tax Assets Unrealized Gain Loss On Long Term Investment", "terseLabel": "Unrealized gain on long term investment" } } }, "localname": "DeferredTaxAssetsUnrealizedGainLossOnLongTermInvestment", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1" ], "xbrltype": "monetaryItemType" }, "emma_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionLossAndOthers": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails2": { "order": 10010.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities unrealized currency transaction loss and others.", "label": "Deferred Tax Liabilities Unrealized Currency Transaction Loss And Others", "negatedLabel": "Unrealized loss on foreign exchange translation and others" } } }, "localname": "DeferredTaxLiabilitiesUnrealizedCurrencyTransactionLossAndOthers", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails2" ], "xbrltype": "monetaryItemType" }, "emma_DescriptionOfBusinessLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of business.", "label": "Description Of Business [Line Items]", "terseLabel": "Description Of Business [Line Items]" } } }, "localname": "DescriptionOfBusinessLineItems", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative" ], "xbrltype": "stringItemType" }, "emma_DescriptionOfBusinessTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of business.", "label": "Description Of Business [Table]", "terseLabel": "Description Of Business [Table]" } } }, "localname": "DescriptionOfBusinessTable", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative" ], "xbrltype": "stringItemType" }, "emma_DescriptionOnDebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of debt instruments terms.", "label": "Description On Debt Instrument Term", "terseLabel": "Term of Loan", "verboseLabel": "Term of Notes" } } }, "localname": "DescriptionOnDebtInstrumentTerm", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "emma_DirectorAndChiefExecutiveOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Director and Chief Executive Officer.", "label": "Director And Chief Executive Officer [Member]", "terseLabel": "Dr. Yutaka Niihara [Member]" } } }, "localname": "DirectorAndChiefExecutiveOfficerMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_DistributionAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Distribution agreement.", "label": "Distribution Agreement [Member]", "terseLabel": "Distribution Agreement [Member]" } } }, "localname": "DistributionAgreementMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_EJHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EJ Holdings Inc.", "label": "E J Holdings Inc [Member]", "terseLabel": "EJ Holding, Inc. [Member]", "verboseLabel": "EJ Holding, Inc. [Member]" } } }, "localname": "EJHoldingsIncMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_EmmausLifeSciencesIncorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Emmaus life sciences, inc.", "label": "Emmaus Life Sciences Incorporation [Member]", "terseLabel": "Emmaus Life Sciences, Inc. [Member]" } } }, "localname": "EmmausLifeSciencesIncorporationMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_EndariMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Endari Member.", "label": "Endari [Member]", "terseLabel": "Endari [Member]" } } }, "localname": "EndariMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails" ], "xbrltype": "domainItemType" }, "emma_EquityMethodInvestment": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10240.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity method investment.", "label": "Equity Method Investment", "terseLabel": "Equity method investment" } } }, "localname": "EquityMethodInvestment", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "emma_EquitySecuritiesFvNiRealizedGainLossExcludingImpairmentLoss": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10220.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity securities fv ni realized gain loss excluding impairment loss.", "label": "Equity Securities Fv Ni Realized Gain Loss Excluding Impairment Loss", "negatedLabel": "Net (gain) losses on investment in marketable securities" } } }, "localname": "EquitySecuritiesFvNiRealizedGainLossExcludingImpairmentLoss", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "emma_FaceAmountOfAccountsReceivableDiscountRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Face amount of accounts receivable discount rate.", "label": "Face Amount Of Accounts Receivable Discount Rate", "terseLabel": "Face amount of accounts receivable discount rate" } } }, "localname": "FaceAmountOfAccountsReceivableDiscountRate", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "percentItemType" }, "emma_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityModification": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, modification.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Modification", "terseLabel": "Fair value at modification date" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityModification", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4" ], "xbrltype": "monetaryItemType" }, "emma_FairValueOfWarrantsIncludingDownRoundProtectionAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of warrants including down-round protection adjustments.", "label": "Fair Value Of Warrants Including Down Round Protection Adjustments", "terseLabel": "Fair value of warrants including down-round protection adjustments" } } }, "localname": "FairValueOfWarrantsIncludingDownRoundProtectionAdjustments", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "monetaryItemType" }, "emma_GPBDebtHoldingsIILLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "GPB Debt Holdings II, LLC.", "label": "G P B Debt Holdings I I L L C [Member]", "terseLabel": "GPB Debt Holdings II, LLC [Member]" } } }, "localname": "GPBDebtHoldingsIILLCMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITTables" ], "xbrltype": "domainItemType" }, "emma_GainLossOnWarrantDerivativeLiabilities": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10270.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10100.0, "parentTag": "emma_NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represents as again loss on warrant derivative liabilities.", "label": "Gain Loss On Warrant Derivative Liabilities", "negatedLabel": "Change in fair value of warrant derivative liabilities", "terseLabel": "Change in fair value of warrant derivative liabilities" } } }, "localname": "GainLossOnWarrantDerivativeLiabilities", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "emma_GoingConcernPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of going concern policy.", "label": "Going Concern Policy [Text Block]", "terseLabel": "Going concern" } } }, "localname": "GoingConcernPolicyTextBlock", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "emma_GovernmentRebatesAndOtherIncentivesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Government rebates and other incentives.", "label": "Government Rebates And Other Incentives [Member]", "terseLabel": "Government Rebates and Other Incentives [Member]" } } }, "localname": "GovernmentRebatesAndOtherIncentivesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails1" ], "xbrltype": "domainItemType" }, "emma_InitialSharesUnderPurchaseAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial shares under purchase agreement.", "label": "Initial Shares Under Purchase Agreement", "terseLabel": "Initial shares under purchase agreement" } } }, "localname": "InitialSharesUnderPurchaseAgreement", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "sharesItemType" }, "emma_InitialWarrantsExercisablePeriodAfterIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial warrants exercisable period after issuance.", "label": "Initial Warrants Exercisable Period After Issuance", "terseLabel": "Initial warrants exercisable period after issuance" } } }, "localname": "InitialWarrantsExercisablePeriodAfterIssuance", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "durationItemType" }, "emma_InterestPayableRelatedPartiesCurrent": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails": { "order": 10020.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all interest payable from related parties.", "label": "Interest Payable Related Parties Current", "terseLabel": "Accrued interest payable, related parties" } } }, "localname": "InterestPayableRelatedPartiesCurrent", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "emma_InventoryReserve": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10180.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Inventory reserve.", "label": "Inventory Reserve", "negatedLabel": "Inventory reserve" } } }, "localname": "InventoryReserve", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "emma_InvestmentInConvertibleBond": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10260.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment in convertible bond.", "label": "Investment In Convertible Bond", "terseLabel": "Investment in convertible bond" } } }, "localname": "InvestmentInConvertibleBond", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "emma_InvestmentInConvertibleBondPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment in convertible bond policy.", "label": "Investment In Convertible Bond Policy Policy [Text Block]", "terseLabel": "Investment in convertible bond" } } }, "localname": "InvestmentInConvertibleBondPolicyPolicyTextBlock", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "emma_InvestmentInConvertibleBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment in convertible bonds.", "label": "Investment In Convertible Bonds [Member]", "terseLabel": "Investment in Convertible Bonds [Member]" } } }, "localname": "InvestmentInConvertibleBondsMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails" ], "xbrltype": "domainItemType" }, "emma_JapanIndustrialPartnersIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Japan Industrial Partners Inc.", "label": "Japan Industrial Partners Inc [Member]", "terseLabel": "Japan Industrial Partners [Member]" } } }, "localname": "JapanIndustrialPartnersIncMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_LeasesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leases.", "label": "Leases [Line Items]", "terseLabel": "Leases [Line Items]" } } }, "localname": "LeasesLineItems", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "stringItemType" }, "emma_LeasesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leases.", "label": "Leases [Table]", "terseLabel": "Leases [Table]" } } }, "localname": "LeasesTable", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "stringItemType" }, "emma_LesseeOperatingLeaseBaseRent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lessee, operating lease, base rent.", "label": "Lessee Operating Lease Base Rent", "terseLabel": "Operating lease, base rental per month" } } }, "localname": "LesseeOperatingLeaseBaseRent", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "emma_LesseeOperatingLeaseBaseRentForAdditionalSpace": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lessee, operating lease, base rent for additional Space.", "label": "Lessee Operating Lease Base Rent For Additional Space", "terseLabel": "Operating lease, additional base rent per month" } } }, "localname": "LesseeOperatingLeaseBaseRentForAdditionalSpace", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "emma_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereafter": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails": { "order": 10050.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.", "label": "Lessee Operating Lease Liability Payments Due Year Five And Thereafter", "terseLabel": "2025 and thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereafter", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails" ], "xbrltype": "monetaryItemType" }, "emma_LiabilityInstrumentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liability instrument warrants.", "label": "Liability Instrument Warrants [Member]", "verboseLabel": "Liability Instrument - Warrants [Member]" } } }, "localname": "LiabilityInstrumentWarrantsMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails2" ], "xbrltype": "domainItemType" }, "emma_LincolnParkCapitalFundLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lincoln Park Capital Fund, L L C.", "label": "Lincoln Park Capital Fund L L C [Member]", "terseLabel": "Lincoln Park Capital Fund, LLC [Member]" } } }, "localname": "LincolnParkCapitalFundLLCMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_LoanToEquityMethodInvestee": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10140.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loan to equity method investee", "label": "Loan To Equity Method Investee", "terseLabel": "Loan to equity method investee" } } }, "localname": "LoanToEquityMethodInvestee", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "emma_LongTermNotesPayableExcludingConvertibleLongTermNotesPayable": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10110.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long term notes payable excluding convertible long term notes payable.", "label": "Long Term Notes Payable Excluding Convertible Long Term Notes Payable", "terseLabel": "Notes payable, less current portion" } } }, "localname": "LongTermNotesPayableExcludingConvertibleLongTermNotesPayable", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "emma_MarketableEquitySecurtiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Marketable equity securties.", "label": "Marketable Equity Securties [Member]", "terseLabel": "Marketable Equity Securities [Member]" } } }, "localname": "MarketableEquitySecurtiesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_MarketableSecuritiesCommonStockOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Marketable securities common stock outstanding.", "label": "Marketable Securities Common Stock Outstanding", "terseLabel": "Marketable securities common stock outstanding" } } }, "localname": "MarketableSecuritiesCommonStockOutstanding", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetailsNarrative" ], "xbrltype": "sharesItemType" }, "emma_MarketableSecuritiesPerShareClosing": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The closing stock price of CellSeed shares, in Japanese Yen.", "label": "Marketable Securities Per Share Closing", "terseLabel": "Investment, closing price" } } }, "localname": "MarketableSecuritiesPerShareClosing", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "perShareItemType" }, "emma_MarketableSecuritiesPurchased": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of the Company's investment in at time of purchase.", "label": "Marketable Securities Purchased", "terseLabel": "Investment" } } }, "localname": "MarketableSecuritiesPurchased", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "emma_MarketableSecuritiesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares in marketable securities (specifically for holdings in CellSeed).", "label": "Marketable Securities Shares", "terseLabel": "Shares held as marketable securities" } } }, "localname": "MarketableSecuritiesShares", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "sharesItemType" }, "emma_MaximumNumberOfCommonSharesElectToSell": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum number of common shares elect to sell.", "label": "Maximum Number Of Common Shares Elect To Sell", "terseLabel": "Maximum number of common shares elect to sell" } } }, "localname": "MaximumNumberOfCommonSharesElectToSell", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "sharesItemType" }, "emma_MaximumPurchaseOfCommonStockInSingleRegularPurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum purchase of common stock in single regular purchase.", "label": "Maximum Purchase Of Common Stock In Single Regular Purchase", "terseLabel": "Maximum purchase of common stock in single regular purchase" } } }, "localname": "MaximumPurchaseOfCommonStockInSingleRegularPurchase", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "emma_MaximumPurchaseSharesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum purchase shares of common stock.", "label": "Maximum Purchase Shares Of Common Stock", "terseLabel": "Maximum purchase shares of common stock" } } }, "localname": "MaximumPurchaseSharesOfCommonStock", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "sharesItemType" }, "emma_MeasurementInputSelectedYieldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input, selected yield.", "label": "Measurement Input Selected Yield [Member]", "terseLabel": "Selected Yield [Member]" } } }, "localname": "MeasurementInputSelectedYieldMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5" ], "xbrltype": "domainItemType" }, "emma_MiscellaneousReverseMergerCosts": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10140.0, "parentTag": "emma_NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Miscellaneous reverse merger costs.", "label": "Miscellaneous Reverse Merger Costs", "negatedLabel": "Miscellaneous reverse merger costs" } } }, "localname": "MiscellaneousReverseMergerCosts", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "emma_NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10080.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Nonoperating income expense including income loss from equity method investments.", "label": "Nonoperating Income Expense Including Income Loss From Equity Method Investments", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "emma_NotesPayableCurrentExcludingConvertibleNotesPayableCurrent": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10180.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Notes payable current excluding convertible notes payable current.", "label": "Notes Payable Current Excluding Convertible Notes Payable Current", "terseLabel": "Notes payable" } } }, "localname": "NotesPayableCurrentExcludingConvertibleNotesPayableCurrent", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "emma_NotesPayableOtherPayables2013Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A written promise to pay a note to a third party. Specific to notes issued in 2013.", "label": "Notes Payable Other Payables2013 [Member]", "terseLabel": "2013 Notes payable [Member]" } } }, "localname": "NotesPayableOtherPayables2013Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails" ], "xbrltype": "domainItemType" }, "emma_NotesPayableOtherPayables2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes payable other payables 2019.", "label": "Notes Payable Other Payables2019 [Member]", "terseLabel": "2019 Notes payable [Member]" } } }, "localname": "NotesPayableOtherPayables2019Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails" ], "xbrltype": "domainItemType" }, "emma_NotesPayableOtherPayables2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes payable other payables 2020.", "label": "Notes Payable Other Payables2020 [Member]", "terseLabel": "2020 Notes payable [Member]" } } }, "localname": "NotesPayableOtherPayables2020Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails" ], "xbrltype": "domainItemType" }, "emma_NotesPayableToRelatedParties2016Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A written promise to pay a note to a related party. Specific to notes issued in 2016.", "label": "Notes Payable To Related Parties2016 [Member]", "terseLabel": "2016 Notes payable - related party [Member]" } } }, "localname": "NotesPayableToRelatedParties2016Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails" ], "xbrltype": "domainItemType" }, "emma_NotesPayableToRelatedParties2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A written promise to pay a note to a third party. Specific to notes issued in 2018.", "label": "Notes Payable To Related Parties2018 [Member]", "terseLabel": "2018 Notes payable - related party [Member]" } } }, "localname": "NotesPayableToRelatedParties2018Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails" ], "xbrltype": "domainItemType" }, "emma_NotesPayableToRelatedParties2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes payable to related parties 2019.", "label": "Notes Payable To Related Parties2019 [Member]", "terseLabel": "2019 Notes payable - related party [Member]" } } }, "localname": "NotesPayableToRelatedParties2019Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails" ], "xbrltype": "domainItemType" }, "emma_NotesPayableToRelatedParties2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes payable to related parties 2020.", "label": "Notes Payable To Related Parties2020 [Member]", "terseLabel": "2020 Notes payable - related party [Member]" } } }, "localname": "NotesPayableToRelatedParties2020Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails" ], "xbrltype": "domainItemType" }, "emma_NotesPayableToRelatedPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A written promise to pay a note to a related party.", "label": "Notes Payable To Related Parties [Member]", "terseLabel": "Notes payable - related party [Member]" } } }, "localname": "NotesPayableToRelatedPartiesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails" ], "xbrltype": "domainItemType" }, "emma_NumberOfCommonStockToBePurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of common stock to be purchased.", "label": "Number Of Common Stock To Be Purchased", "terseLabel": "Number of common stock to be purchased" } } }, "localname": "NumberOfCommonStockToBePurchased", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "sharesItemType" }, "emma_NumberOfRenewals": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of renewals for revised supply agreement.", "label": "Number Of Renewals", "terseLabel": "Number of renewals" } } }, "localname": "NumberOfRenewals", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative" ], "xbrltype": "integerItemType" }, "emma_NumberOfVendors": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of vendors.", "label": "Number Of Vendors", "terseLabel": "Number of vendors" } } }, "localname": "NumberOfVendors", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "integerItemType" }, "emma_OperatingLeaseAdditionalSpaceForRent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating lease, additional space for rent.", "label": "Operating Lease Additional Space For Rent", "terseLabel": "Operating lease, additional space for rent" } } }, "localname": "OperatingLeaseAdditionalSpaceForRent", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "areaItemType" }, "emma_OperatingLeaseLeasedSpaceForRent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating lease, Leased space for rent.", "label": "Operating Lease Leased Space For Rent", "terseLabel": "Operating lease, leased space" } } }, "localname": "OperatingLeaseLeasedSpaceForRent", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "areaItemType" }, "emma_OperatingLossCarryforwardsExpirationYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration year of each operating loss carryforward included in operating loss carryforward, in CCYY format.", "label": "Operating Loss Carryforwards Expiration Year", "terseLabel": "Operating loss carryforwards expiration year" } } }, "localname": "OperatingLossCarryforwardsExpirationYear", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetailsNarrative" ], "xbrltype": "gYearItemType" }, "emma_OrphanDrugDesignationProvidesAdditionalMarketingExclusivityPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Orphan Drug designation provides additional marketing exclusivity period.", "label": "Orphan Drug Designation Provides Additional Marketing Exclusivity Period", "terseLabel": "Orphan drug designation provides additional marketing exclusivity period" } } }, "localname": "OrphanDrugDesignationProvidesAdditionalMarketingExclusivityPeriod", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative" ], "xbrltype": "durationItemType" }, "emma_OrphanDrugDesignationProvidesMarketExclusivityPeriodAfterMarketingApproval": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Orphan Drug designation provides market exclusivity period after marketing approval.", "label": "Orphan Drug Designation Provides Market Exclusivity Period After Marketing Approval", "terseLabel": "Orphan drug designation provides market exclusivity period after marketing approval" } } }, "localname": "OrphanDrugDesignationProvidesMarketExclusivityPeriodAfterMarketingApproval", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative" ], "xbrltype": "durationItemType" }, "emma_OtherLongTermLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other long-term liabilities.", "label": "Other Long Term Liabilities [Line Items]", "terseLabel": "Other Long Term Liabilities [Line Items]" } } }, "localname": "OtherLongTermLiabilitiesLineItems", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails1" ], "xbrltype": "stringItemType" }, "emma_OtherLongTermLiabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other long-term liabilities.", "label": "Other Long Term Liabilities [Table]", "terseLabel": "Other Long Term Liabilities [Table]" } } }, "localname": "OtherLongTermLiabilitiesTable", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails1" ], "xbrltype": "stringItemType" }, "emma_PaycheckProtectionProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paycheck protection program.", "label": "Paycheck Protection Program [Member]", "terseLabel": "Paycheck Protection Program [Member]" } } }, "localname": "PaycheckProtectionProgramMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_PaymentsForPurchaseOfConvertibleDebt": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10130.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Payments for purchase of convertible debt", "label": "Payments For Purchase Of Convertible Debt", "terseLabel": "Purchase of convertible bonds" } } }, "localname": "PaymentsForPurchaseOfConvertibleDebt", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "emma_PercentageOfFaceAmountOfApplicableAtTimeOfSaleAccountsReceivable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of face amount of applicable at time of sale accounts receivable.", "label": "Percentage Of Face Amount Of Applicable At Time Of Sale Accounts Receivable", "terseLabel": "Percentage of face amount of applicable at time of sale accounts receivable" } } }, "localname": "PercentageOfFaceAmountOfApplicableAtTimeOfSaleAccountsReceivable", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "percentItemType" }, "emma_PercentageOfFaceAmountOfApplicableSubjectToIncreaseAtTimeOfSaleAccountsReceivable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of face amount of applicable subject to increase at time of sale accounts receivable.", "label": "Percentage Of Face Amount Of Applicable Subject To Increase At Time Of Sale Accounts Receivable", "terseLabel": "Percentage of face amount of applicable subject to increase at time of sale accounts receivable" } } }, "localname": "PercentageOfFaceAmountOfApplicableSubjectToIncreaseAtTimeOfSaleAccountsReceivable", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "percentItemType" }, "emma_PercentageOfMarketableSecuritiesCommonStockOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of marketable securities common stock outstanding.", "label": "Percentage Of Marketable Securities Common Stock Outstanding", "terseLabel": "Percentage of marketable securities common stock outstanding" } } }, "localname": "PercentageOfMarketableSecuritiesCommonStockOutstanding", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetailsNarrative" ], "xbrltype": "percentItemType" }, "emma_PercentageOfOriginalIssueDiscount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of original issue discount.", "label": "Percentage Of Original Issue Discount", "terseLabel": "Original issue discount percentage" } } }, "localname": "PercentageOfOriginalIssueDiscount", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "percentItemType" }, "emma_PercentageOfPrincipalAmountOfConvertibleBondToBeRepurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of principal amount of convertible bond to be repurchased.", "label": "Percentage Of Principal Amount Of Convertible Bond To Be Repurchased", "terseLabel": "Percentage of principal amount of convertible bond to be repurchased" } } }, "localname": "PercentageOfPrincipalAmountOfConvertibleBondToBeRepurchased", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "percentItemType" }, "emma_PercentageOfRightToSupply": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of right to supply.", "label": "Percentage Of Right To Supply", "terseLabel": "Percentage of right to supply" } } }, "localname": "PercentageOfRightToSupply", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative" ], "xbrltype": "percentItemType" }, "emma_PharmaceuticalGradeLGlutamineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pharmaceutical grade L-glutamine.", "label": "Pharmaceutical Grade L Glutamine [Member]", "terseLabel": "PGLG [Member]" } } }, "localname": "PharmaceuticalGradeLGlutamineMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire policy disclosure regarding prepaid expenses and other current assets.", "label": "Prepaid Expenses And Other Current Assets Policy [Text Block]", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "emma_PrestigeCapitalFinanceLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prestige Capital Finance, LLC.", "label": "Prestige Capital Finance L L C [Member]", "terseLabel": "Prestige Capital Finance, LLC [Member]" } } }, "localname": "PrestigeCapitalFinanceLLCMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_PrestigeCapitalFinanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prestige Capital Finance LLC.", "label": "Prestige Capital Finance [Member]", "terseLabel": "Prestige Capital Finance, LLC [Member]" } } }, "localname": "PrestigeCapitalFinanceMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_PriorToTwoThousandNineteenWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prior to two thousand nineteen warrant.", "label": "Prior To Two Thousand Nineteen Warrant [Member]", "terseLabel": "Warrants Issued Prior to January 1, 2019 [Member]" } } }, "localname": "PriorToTwoThousandNineteenWarrantMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "domainItemType" }, "emma_PriorToTwoThousandNineteenWarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prior to two thousand nineteen warrant one.", "label": "Prior To Two Thousand Nineteen Warrant One [Member]", "terseLabel": "Warrants Issued Prior to January 1, 2019 - Exercise Price $4.29-$10.28 [Member]" } } }, "localname": "PriorToTwoThousandNineteenWarrantOneMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "domainItemType" }, "emma_ProceedsFromSupplyAgreement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from consideration for the right to supply goods.", "label": "Proceeds From Supply Agreement", "terseLabel": "Proceeds from supply agreement" } } }, "localname": "ProceedsFromSupplyAgreement", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties24Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 24.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties24 [Member]", "terseLabel": "Lan T. Tran [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties24Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties27Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 27.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties27 [Member]", "terseLabel": "Yutaka & Soomi Niihara [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties27Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties44Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 44.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties44 [Member]", "terseLabel": "Yasushi Nagasaki [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties44Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties50Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 50.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties50 [Member]", "terseLabel": "Wei Peu Zen [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties50Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties51Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 51.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties51 [Member]", "terseLabel": "Profit Preview International Group, Ltd. [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties51Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties52Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 52.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties52 [Member]", "terseLabel": "Profit Preview International Group, Ltd. [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties52Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties64Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 64.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties64 [Member]", "terseLabel": "Hope International Hospice, Inc. [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties64Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties65Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 65.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties65 [Member]", "terseLabel": "Lan T. Tran [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties65Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties69Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 69.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties69 [Member]", "terseLabel": "Yutaka Niihara [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties69Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties70Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 70.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties70 [Member]", "terseLabel": "Lan T. Tran [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties70Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties79Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 79.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties79 [Member]", "terseLabel": "Lan T. Tran [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties79Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties81Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 81.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties81 [Member]", "terseLabel": "Hope International Homecare [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties81Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties82Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 82.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties82 [Member]", "terseLabel": "Soomi Niihara [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties82Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties83Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 83.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties83 [Member]", "terseLabel": "Soomi Niihara [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties83Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties84Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 84.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties84 [Member]", "terseLabel": "Willis Lee [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties84Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties85Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and convertible notes payable to related parties 85.", "label": "Promissory Note Payable And Convertible Notes Payable To Related Parties85 [Member]", "terseLabel": "Willis Lee [Member]" } } }, "localname": "PromissoryNotePayableAndConvertibleNotesPayableToRelatedParties85Member", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableConvertibleNotePayableAndRevolvingLineOfCreditToRelatedPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable convertible note payable and revolving line of credit to related parties.", "label": "Promissory Note Payable Convertible Note Payable And Revolving Line Of Credit To Related Parties [Member]", "terseLabel": "Promissory note payable and convertible notes payable - related party [Member]" } } }, "localname": "PromissoryNotePayableConvertibleNotePayableAndRevolvingLineOfCreditToRelatedPartiesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayableToRelatedPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable to related parties.", "label": "Promissory Note Payable To Related Parties [Member]", "terseLabel": "Promissory note payable to related parties [Member]" } } }, "localname": "PromissoryNotePayableToRelatedPartiesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PromissoryNotePayablesAndRevolvingLineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note payable and revolving line of credit.", "label": "Promissory Note Payables And Revolving Line Of Credit [Member]", "terseLabel": "Promissory note payable and Revolving line of credit [Member]" } } }, "localname": "PromissoryNotePayablesAndRevolvingLineOfCreditMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_PurchaseAgreementWithTenPercentageSeniorSecuredDebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase agreement with ten percentage senior secured debentures.", "label": "Purchase Agreement With Ten Percentage Senior Secured Debentures [Member]", "terseLabel": "Purchase Agreement With 10% Senior Secured Debentures [Member]" } } }, "localname": "PurchaseAgreementWithTenPercentageSeniorSecuredDebenturesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_PurchaseAndSaleAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase and sale agreement.", "label": "Purchase And Sale Agreement [Member]", "terseLabel": "Purchase and Sale Agreement [Member]" } } }, "localname": "PurchaseAndSaleAgreementMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_PurchaseOfConvertibleBondAtFaceValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase of convertible bond at face value.", "label": "Purchase Of Convertible Bond At Face Value", "terseLabel": "Purchase of principal amount of convertible bond at face value" } } }, "localname": "PurchaseOfConvertibleBondAtFaceValue", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "emma_ReceivedNonRefundableDeposits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Received non refundable deposits.", "label": "Received Non Refundable Deposits", "positiveLabel": "Received non refundable deposits" } } }, "localname": "ReceivedNonRefundableDeposits", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "emma_ReturnsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Returns.", "label": "Returns [Member]", "terseLabel": "Returns [Member]" } } }, "localname": "ReturnsMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails1" ], "xbrltype": "domainItemType" }, "emma_RevenueAllowanceAndAccrualActivities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Revenue allowance and accrual activities.", "label": "Revenue Allowance And Accrual Activities", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "RevenueAllowanceAndAccrualActivities", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails1" ], "xbrltype": "monetaryItemType" }, "emma_RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Revenue allowance and accrual activities adjustments related to prior period sales.", "label": "Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales", "negatedLabel": "Adjustments related to prior period sales" } } }, "localname": "RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails1" ], "xbrltype": "monetaryItemType" }, "emma_RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Revenue allowance and accrual activities, credit and payments made.", "label": "Revenue Allowance And Accrual Activities Credit And Payments Made", "negatedLabel": "Credit and payments made" } } }, "localname": "RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails1" ], "xbrltype": "monetaryItemType" }, "emma_RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Revenue allowance and accrual activities provision related to sales in the current year.", "label": "Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year", "terseLabel": "Provision related to sales in the current year" } } }, "localname": "RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails1" ], "xbrltype": "monetaryItemType" }, "emma_RevenueAllowanceAndAccrualActivitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue allowance and accrual activities.", "label": "Revenue Allowance And Accrual Activities Table [Text Block]", "terseLabel": "Revenue Allowance and Accrual Activities" } } }, "localname": "RevenueAllowanceAndAccrualActivitiesTableTextBlock", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESTables" ], "xbrltype": "textBlockItemType" }, "emma_RevisedAPISuppyAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.", "label": "Revised A P I Suppy Agreement [Member]", "terseLabel": "Revised API Agreement [Member]" } } }, "localname": "RevisedAPISuppyAgreementMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_RevolvingLineOfCreditsRelatedPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revolving line of credit related parties.", "label": "Revolving Line Of Credits Related Parties [Member]", "terseLabel": "Yutaka Niihara [Member]" } } }, "localname": "RevolvingLineOfCreditsRelatedPartiesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "emma_STIP2011PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the 2011 Stock Incentive Option Plan.", "label": "S T I P2011 Plan [Member]", "terseLabel": "2011 Stock Incentive Option Plan [Member]" } } }, "localname": "STIP2011PlanMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_ScheduleOfSummaryOfSignificantAccountingPolicyTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of summary of significant accounting policy.", "label": "Schedule Of Summary Of Significant Accounting Policy [Table]", "terseLabel": "Schedule Of Summary Of Significant Accounting Policy [Table]" } } }, "localname": "ScheduleOfSummaryOfSignificantAccountingPolicyTable", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "stringItemType" }, "emma_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities purchase agreement.", "label": "Securities Purchase Agreement [Member]", "terseLabel": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_SeniorSecuredConvertiblePromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured convertible promissory note.", "label": "Senior Secured Convertible Promissory Note [Member]", "terseLabel": "Senior Secured Convertible Promissory Note [Member]" } } }, "localname": "SeniorSecuredConvertiblePromissoryNoteMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_SeniorSecuredDebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured debentures.", "label": "Senior Secured Debentures [Member]", "terseLabel": "Senior Secured Convertible Debentures [Member]" } } }, "localname": "SeniorSecuredDebenturesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITTables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_ShareBasedCompensationAndFairValueOfReplacementEquityAward": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10250.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share based compensation and fair value of replacement equity award.", "label": "Share Based Compensation And Fair Value Of Replacement Equity Award", "terseLabel": "Share-based compensation and fair value of replacement equity award" } } }, "localname": "ShareBasedCompensationAndFairValueOfReplacementEquityAward", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "emma_StockIssuedDuringPeriodSharesExerciseOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares exercise of warrants.", "label": "Stock Issued During Period Shares Exercise Of Warrants", "terseLabel": "Exercise of warrants (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesExerciseOfWarrants", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "sharesItemType" }, "emma_StockIssuedDuringPeriodValueExerciseOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value exercise of warrants.", "label": "Stock Issued During Period Value Exercise Of Warrants", "terseLabel": "Exercise of warrants" } } }, "localname": "StockIssuedDuringPeriodValueExerciseOfWarrants", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "monetaryItemType" }, "emma_StockIssuedDuringPeriodValueMerger": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value, merger.", "label": "Stock Issued During Period Value Merger", "terseLabel": "Common stock issued in merger" } } }, "localname": "StockIssuedDuringPeriodValueMerger", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "monetaryItemType" }, "emma_SummaryOfSignificantAccountingPolicyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of significant accounting policy.", "label": "Summary Of Significant Accounting Policy [Line Items]", "terseLabel": "Summary of Significant Accounting Policy [Line Items]" } } }, "localname": "SummaryOfSignificantAccountingPolicyLineItems", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "stringItemType" }, "emma_TaibaMiddleEastFZLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Taiba Middle East FZ LLC.", "label": "Taiba Middle East F Z L L C [Member]", "terseLabel": "Taiba Middle East FZ LLC [Member]" } } }, "localname": "TaibaMiddleEastFZLLCMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_TelconIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.", "label": "Telcon Inc [Member]", "terseLabel": "Telcon, Inc. (\"Telcon\") [Member]", "verboseLabel": "Telcon, Inc. (\"Telcon\") [Member]" } } }, "localname": "TelconIncMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_TelconRFPharmaceuticalsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Telcon RF Pharmaceuticals, Inc.", "label": "Telcon R F Pharmaceuticals Inc [Member]", "verboseLabel": "Telcon RF Pharmaceuticals, Inc. (\"Telcon\") [Member]" } } }, "localname": "TelconRFPharmaceuticalsIncMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_TenPercentSeniorSecuredConvertibleDebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "10% senior secured convertible debentures.", "label": "Ten Percent Senior Secured Convertible Debentures [Member]", "terseLabel": "10% Senior Secured Convertible Debentures [Member]" } } }, "localname": "TenPercentSeniorSecuredConvertibleDebenturesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_TenPercentageOfSeniorSecuredConvertibleDebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ten percentage of senior secured convertible debentures.", "label": "Ten Percentage Of Senior Secured Convertible Debentures [Member]", "terseLabel": "10% Senior Secured Convertible Debentures [Member]" } } }, "localname": "TenPercentageOfSeniorSecuredConvertibleDebenturesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails2" ], "xbrltype": "domainItemType" }, "emma_TenPercentageOfSeniorSecuredDebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ten percentage of senior secured debentures.", "label": "Ten Percentage Of Senior Secured Debentures [Member]", "terseLabel": "10% of Senior Secured Debentures [Member]", "verboseLabel": "10% Secured Senior Debentures [Member]" } } }, "localname": "TenPercentageOfSeniorSecuredDebenturesMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "emma_TerminationCostOrPenalty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Termination cost or penalty.", "label": "Termination Cost Or Penalty", "verboseLabel": "Termination cost or penalty" } } }, "localname": "TerminationCostOrPenalty", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "emma_TradeDiscountMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trade discount.", "label": "Trade Discount [Member]", "terseLabel": "Trade Discount [Member]" } } }, "localname": "TradeDiscountMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails1" ], "xbrltype": "domainItemType" }, "emma_TradeDiscountsAllowancesAndChargebacksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trade discounts, allowances and chargebacks.", "label": "Trade Discounts Allowances And Chargebacks [Member]", "terseLabel": "Trade Discounts, Allowances and Chargebacks [Member]" } } }, "localname": "TradeDiscountsAllowancesAndChargebacksMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails1" ], "xbrltype": "domainItemType" }, "emma_TwoThousandNineteenWarrantFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 warrant five.", "label": "Two Thousand Nineteen Warrant Five [Member]", "terseLabel": "Warrants Issued in 2019 - Exercise Price $36.24 [Member]" } } }, "localname": "TwoThousandNineteenWarrantFiveMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "domainItemType" }, "emma_TwoThousandNineteenWarrantFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 warrant four.", "label": "Two Thousand Nineteen Warrant Four [Member]", "terseLabel": "Warrants Issued in 2019 - Exercise Price $31.50 [Member]" } } }, "localname": "TwoThousandNineteenWarrantFourMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "domainItemType" }, "emma_TwoThousandNineteenWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 warrant.", "label": "Two Thousand Nineteen Warrant [Member]", "terseLabel": "Warrants Issued in 2019 [Member]" } } }, "localname": "TwoThousandNineteenWarrantMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "domainItemType" }, "emma_TwoThousandNineteenWarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 warrant one.", "label": "Two Thousand Nineteen Warrant One [Member]", "terseLabel": "Warrants Issued in 2019 - Exercise Price $ 6.12 [Member]" } } }, "localname": "TwoThousandNineteenWarrantOneMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "domainItemType" }, "emma_TwoThousandNineteenWarrantSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 warrant seven.", "label": "Two Thousand Nineteen Warrant Seven [Member]", "terseLabel": "Warrants Issued in 2019 - Exercise Price $7.68 [Member]" } } }, "localname": "TwoThousandNineteenWarrantSevenMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "domainItemType" }, "emma_TwoThousandNineteenWarrantSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 warrant six.", "label": "Two Thousand Nineteen Warrant Six [Member]", "terseLabel": "Warrants Issued in 2019 - Exercise Price $5.87 [Member]" } } }, "localname": "TwoThousandNineteenWarrantSixMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "domainItemType" }, "emma_TwoThousandNineteenWarrantThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 warrant three.", "label": "Two Thousand Nineteen Warrant Three [Member]", "terseLabel": "Warrants Issued in 2019 - Exercise Price $14.04 [Member]" } } }, "localname": "TwoThousandNineteenWarrantThreeMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "domainItemType" }, "emma_TwoThousandNineteenWarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 warrant two.", "label": "Two Thousand Nineteen Warrant Two [Member]", "terseLabel": "Warrants Issued in 2019 - Exercise Price $12.00 [Member]" } } }, "localname": "TwoThousandNineteenWarrantTwoMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "domainItemType" }, "emma_TwoThousandTwentyWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2020 warrant.", "label": "Two Thousand Twenty Warrant [Member]", "terseLabel": "Warrants Issued in 2020 [Member]" } } }, "localname": "TwoThousandTwentyWarrantMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "domainItemType" }, "emma_TwoThousandTwentyWarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand Twenty Warrant One [Member].", "label": "Two Thousand Twenty Warrant One [Member]", "terseLabel": "Warrants Issued in 2020 - Exercise Price $2.10 [Member]" } } }, "localname": "TwoThousandTwentyWarrantOneMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "domainItemType" }, "emma_TwoThousandTwentyWarrantThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2020 warrant three.", "label": "Two Thousand Twenty Warrant Three [Member]", "terseLabel": "Warrants Issued in 2020 - Exercise Price $2.00 [Member]" } } }, "localname": "TwoThousandTwentyWarrantThreeMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "domainItemType" }, "emma_TwoThousandTwentyWarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2020 warrant two.", "label": "Two Thousand Twenty Warrant Two [Member]", "terseLabel": "Warrants Issued in 2020 - Exercise Price $2.05 [Member]" } } }, "localname": "TwoThousandTwentyWarrantTwoMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "domainItemType" }, "emma_UnearnedRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unearned revenue.", "label": "Unearned Revenue [Member]", "terseLabel": "Unearned Revenue [Member]" } } }, "localname": "UnearnedRevenueMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails1" ], "xbrltype": "domainItemType" }, "emma_UnitPriceOfGradeLGlutamine": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The unit price of grade L-glutamine per raw material supply agreement.", "label": "Unit Price Of Grade L Glutamine", "terseLabel": "Unit price of grade L-glutamine" } } }, "localname": "UnitPriceOfGradeLGlutamine", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative" ], "xbrltype": "perUnitItemType" }, "emma_UnsecuredLongTermDebtAdditionalBorrowing": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unsecured long term debt additional borrowing.", "label": "Unsecured Long Term Debt Additional Borrowing", "positiveVerboseLabel": "Unsecured debt, additional borrowings" } } }, "localname": "UnsecuredLongTermDebtAdditionalBorrowing", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "emma_UpfrontPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Upfront payment.", "label": "Upfront Payment", "verboseLabel": "Upfront payment" } } }, "localname": "UpfrontPayment", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "emma_ValuationTechniqueBinomialMonteCarloCliquetOptionPricingModelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valuation technique binomial monte-carlo cliquet option pricing model.", "label": "Valuation Technique Binomial Monte Carlo Cliquet Option Pricing Model [Member]", "terseLabel": "Valuation Technique Binomial Monte-Carlo Cliquet Option Pricing Model [Member]" } } }, "localname": "ValuationTechniqueBinomialMonteCarloCliquetOptionPricingModelMember", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5" ], "xbrltype": "domainItemType" }, "emma_WarrantAndConversionFeatureReclassifiedToEquity": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Warrant and conversion feature reclassified to equity.", "label": "Warrant And Conversion Feature Reclassified To Equity", "terseLabel": "Warrant and conversion feature reclassified to equity" } } }, "localname": "WarrantAndConversionFeatureReclassifiedToEquity", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "monetaryItemType" }, "emma_WarrantLiabilitiesReclassificationToEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant liabilities reclassification to equity.", "label": "Warrant Liabilities Reclassification To Equity", "terseLabel": "Warrant liabilities reclassified to equity" } } }, "localname": "WarrantLiabilitiesReclassificationToEquity", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "emma_WarrantOfAssumedAsPartOfMerger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant of assumed as part of merger.", "label": "Warrant Of Assumed As Part Of Merger", "terseLabel": "Assumed as part of Merger" } } }, "localname": "WarrantOfAssumedAsPartOfMerger", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails4" ], "xbrltype": "sharesItemType" }, "emma_WarrantsAndRightsOutstandingMeasurementInputs": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants and rights outstanding, measurement inputs.", "label": "Warrants And Rights Outstanding Measurement Inputs", "terseLabel": "Risk-free rate" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInputs", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5" ], "xbrltype": "stringItemType" }, "emma_WarrantsCancelledForfeitedAndExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of warrants cancelled, forfeited and expired during the period.", "label": "Warrants Cancelled Forfeited And Expired", "negatedLabel": "Cancelled, forfeited and expired" } } }, "localname": "WarrantsCancelledForfeitedAndExpired", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails4" ], "xbrltype": "sharesItemType" }, "emma_WarrantsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of warrants exercisable as of the balance sheet date.", "label": "Warrants Exercisable", "terseLabel": "Total, Exercisable" } } }, "localname": "WarrantsExercisable", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "sharesItemType" }, "emma_WarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of warrants exercised during the period.", "label": "Warrants Exercised", "negatedLabel": "Exercised" } } }, "localname": "WarrantsExercised", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails4" ], "xbrltype": "sharesItemType" }, "emma_WarrantsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of warrants granted during the period.", "label": "Warrants Granted", "terseLabel": "Deemed Granted" } } }, "localname": "WarrantsGranted", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails4" ], "xbrltype": "sharesItemType" }, "emma_WarrantsWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price per share or per unit of warrants or rights outstanding.", "label": "Warrants Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Outstanding" } } }, "localname": "WarrantsWeightedAverageExercisePrice", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "perShareItemType" }, "emma_WeightedAverageExercisePriceExercisableWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price for exercisable warrants when converting warrants into shares.", "label": "Weighted Average Exercise Price Exercisable Warrants", "terseLabel": "Weighted Average Exercise Price, Exercisable" } } }, "localname": "WeightedAverageExercisePriceExercisableWarrants", "nsuri": "http://www.emmausmedical.com/20201231", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "perShareItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r389", "r390", "r395", "r396", "r564", "r574" ], "lang": { "en-us": { "role": { "documentation": "Information by consolidated entity or group of entities.", "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r389", "r390", "r395", "r396" ], "lang": { "en-us": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity.", "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.", "label": "Contractual Obligation Fiscal Year Maturity Schedule Table [Text Block]", "terseLabel": "Schedule of future contractual principal payments of notes payable" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables" ], "xbrltype": "textBlockItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r73", "r130", "r576" ], "lang": { "en-us": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITTables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r145", "r152", "r227", "r337", "r338", "r339", "r371", "r372" ], "lang": { "en-us": { "role": { "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect Period Of Adoption Adjustment [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment [Member]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r145", "r152", "r227", "r337", "r338", "r339", "r371", "r372" ], "lang": { "en-us": { "role": { "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect Period Of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r145", "r152", "r227", "r337", "r338", "r339", "r371", "r372" ], "lang": { "en-us": { "role": { "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect Period Of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of investment, including named security. Excludes consolidated entity.", "label": "Equity Method Investee Name [Domain]", "terseLabel": "Investment, Name" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r207", "r283", "r287", "r515" ], "lang": { "en-us": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Major Customers [Axis]", "terseLabel": "Customer" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails2" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r304", "r306", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r512", "r516" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDEFINEDCONTRIBUTIONPLANDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r304", "r306", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r512", "r516" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDEFINEDCONTRIBUTIONPLANDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r207", "r283", "r287", "r515" ], "lang": { "en-us": { "role": { "documentation": "Single external customer or group of external customers.", "label": "Name Of Major Customer [Domain]", "terseLabel": "Customer" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails2" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r204", "r283", "r285", "r472", "r511", "r513" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product Or Service [Axis]", "terseLabel": "Product and Service" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r204", "r283", "r285", "r472", "r511", "r513" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Products And Services [Domain]", "terseLabel": "Product and Service" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r294", "r304", "r306", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r512", "r516" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Range [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDEFINEDCONTRIBUTIONPLANDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r294", "r304", "r306", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r512", "r516" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Range [Member]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDEFINEDCONTRIBUTIONPLANDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Repurchase Agreement Counterparty Name [Domain]", "terseLabel": "Counterparty Name" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITTables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Information by name of investment, including named security. Excludes consolidated entity.", "label": "Schedule Of Equity Method Investment Equity Method Investee Name [Axis]", "terseLabel": "Investment, Name" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r205", "r206", "r283", "r286", "r514", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Segment Geographical [Domain]", "terseLabel": "Geographical" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r205", "r206", "r283", "r286", "r514", "r551", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r573", "r575" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Statement Geographical [Axis]", "terseLabel": "Geographical" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r297", "r455", "r456", "r459" ], "lang": { "en-us": { "role": { "documentation": "Entity owned or controlled by another entity.", "label": "Subsidiaries [Member]", "terseLabel": "Telemynd [Member]" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r208", "r458" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title Of Individual [Axis]", "terseLabel": "Title of Individual" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title Of Individual With Relationship To Entity [Domain]", "terseLabel": "Title of Individual" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "domainItemType" }, "stpr_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CALIFORNIA", "terseLabel": "Torrance, California [Member]" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "domainItemType" }, "stpr_NY": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NEW YORK", "terseLabel": "New York [Member]" } } }, "localname": "NY", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201602Member": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).", "label": "Accounting Standards Update201602 [Member]", "terseLabel": "ASU 2016-02 [Member]" } } }, "localname": "AccountingStandardsUpdate201602Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201613Member": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.", "label": "Accounting Standards Update201613 [Member]", "terseLabel": "ASU 2016-13 [Member]" } } }, "localname": "AccountingStandardsUpdate201613Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201813Member": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2018-13 Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement.", "label": "Accounting Standards Update201813 [Member]", "terseLabel": "ASU 2018-13 [Member]" } } }, "localname": "AccountingStandardsUpdate201813Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Information by type of receivable.", "label": "Accounts Notes Loans And Financing Receivable By Receivable Type [Axis]", "terseLabel": "Receivable Type" } } }, "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r51" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10130.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable And Accrued Liabilities Current", "terseLabel": "Accounts payable and accrued expenses", "totalLabel": "Total accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable And Accrued Liabilities Disclosure [Text Block]", "terseLabel": "SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails": { "order": 10010.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable Current", "terseLabel": "Total accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableOtherCurrent": { "auth_ref": [ "r11", "r47" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts Payable Other Current", "terseLabel": "Other vendors" } } }, "localname": "AccountsPayableOtherCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrent": { "auth_ref": [ "r47", "r133", "r457", "r459" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable Related Parties Current", "verboseLabel": "Accounts payables outstanding" } } }, "localname": "AccountsPayableRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r3", "r28", "r209", "r210" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10290.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable Net Current", "terseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r54" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails": { "order": 10040.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities Current", "totalLabel": "Total accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accrued Liabilities Current [Abstract]", "terseLabel": "Accrued expenses:" } } }, "localname": "AccruedLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccruedPayrollTaxesCurrent": { "auth_ref": [ "r11", "r54" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails": { "order": 10050.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Payroll Taxes Current", "terseLabel": "Payroll expenses" } } }, "localname": "AccruedPayrollTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r10", "r11", "r54" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees Current", "terseLabel": "Professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalesCommissionCurrent": { "auth_ref": [ "r10", "r11", "r54" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Sales Commission Current", "terseLabel": "Selling expenses" } } }, "localname": "AccruedSalesCommissionCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r44", "r244" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails2": { "order": 10020.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r31", "r78", "r79", "r80", "r499", "r524", "r528" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10060.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income Loss Net Of Tax", "terseLabel": "Accumulated other comprehensive Income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r77", "r80", "r81", "r142", "r143", "r144", "r394", "r519", "r520" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r29" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10050.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid In Capital Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r142", "r143", "r144", "r337", "r338", "r339" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid In Capital [Member]", "terseLabel": "Additional Paid-In Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r146", "r147", "r148", "r149", "r224", "r225", "r226", "r227", "r229", "r230", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r369", "r370", "r371", "r372", "r473", "r474", "r475", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Adjustments For New Accounting Pronouncements [Axis]", "terseLabel": "Accounting Standards Update" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": { "auth_ref": [ "r263", "r269", "r368" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.", "label": "Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature", "terseLabel": "Beneficial conversion feature relating to convertible notes payable" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": { "auth_ref": [ "r254" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.", "label": "Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt", "terseLabel": "Conversion of convertible notes payable and notes payable to common stock" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r307", "r309", "r342", "r343" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value", "terseLabel": "Share-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash flows from operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AlternativeInvestment": { "auth_ref": [ "r402", "r413" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment other than investment in equity security, investment in debt security and equity method investment. Includes, but is not limited to, investment in certain entities that calculate net asset value per share. Example includes, but is not limited to, investment in hedge fund, venture capital fund, private equity fund, and real estate partnership or fund.", "label": "Alternative Investment", "terseLabel": "Principal outstanding (South Korean won)" } } }, "localname": "AlternativeInvestment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_AlternativeInvestmentMeasurementInput": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure alternative investment.", "label": "Alternative Investment Measurement Input", "terseLabel": "Investment in convertible bonds, measurement input" } } }, "localname": "AlternativeInvestmentMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1" ], "xbrltype": "decimalItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r99", "r114", "r437" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10190.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization Of Debt Discount Premium", "terseLabel": "Amortization of discount of notes payable and convertible notes payable" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Arrangements And Nonarrangement Transactions [Member]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r127", "r187", "r196", "r202", "r221", "r389", "r395", "r421", "r477", "r496" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r8", "r72", "r127", "r221", "r389", "r395", "r421" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10220.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Current", "terseLabel": "CURRENT ASSETS", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Current [Abstract]", "terseLabel": "CURRENT ASSETS" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r310", "r332" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r399", "r400" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_BalanceSheetRelatedDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Balance Sheet Related Disclosures [Abstract]" } } }, "localname": "BalanceSheetRelatedDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis Of Accounting Policy Policy [Text Block]", "terseLabel": "Basis of presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r303", "r305" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r303", "r305", "r384", "r385" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.", "label": "Business Acquisition Cost Of Acquired Entity Transaction Costs", "verboseLabel": "Investment amount" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition Percentage Of Voting Interests Acquired", "verboseLabel": "Percentage of voting interest" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r1", "r40", "r116" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10280.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash And Cash Equivalents At Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r17", "r117", "r123" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash And Cash Equivalents Policy [Text Block]", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r109", "r116", "r121" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations", "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r109", "r426" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]", "terseLabel": "NON-CASH INVESTMENT AND FINANCING ACTIVITIES" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": { "auth_ref": [ "r146", "r157", "r228", "r340", "r373" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.", "label": "Change In Accounting Principle Accounting Standards Update Immaterial Effect", "terseLabel": "Change in accounting principle accounting standards update, immaterial effect" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r272", "r308" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class Of Warrant Or Right [Axis]", "terseLabel": "Class of Warrant or Right" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class Of Warrant Or Right [Domain]", "terseLabel": "Class of Warrant or Right" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1", "terseLabel": "Debt instrument exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class Of Warrant Or Right [Line Items]", "terseLabel": "Class Of Warrant Or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights", "terseLabel": "Debt face amount percentage" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class Of Warrant Or Right Outstanding", "periodEndLabel": "Warrants outstanding, ending", "periodStartLabel": "Warrants outstanding, beginning", "positiveLabel": "Number outstanding", "terseLabel": "Number of Warrants Issued, Outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r272", "r308" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class Of Warrant Or Right [Table]", "terseLabel": "Class Of Warrant Or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments And Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r247", "r248", "r249", "r250" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r142", "r143" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock Par Or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock Shares Authorized", "terseLabel": "Common stock, authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares Issued", "terseLabel": "Common stock, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r27", "r263" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock Shares Outstanding", "terseLabel": "Common stock, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r27" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10040.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock Value", "terseLabel": "Common stock \u2014 par value $0.001 per share, 250,000,000 shares authorized, shares 48,987,189 and 48,471,446 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Compensation And Retirement Disclosure [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r122", "r315" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Compensation Related Costs Policy [Text Block]", "terseLabel": "Share-based compensation" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r84", "r86", "r87", "r95", "r487", "r507" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax", "totalLabel": "COMPREHENSIVE INCOME (LOSS)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income Policy Policy [Text Block]", "terseLabel": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r173", "r174", "r207", "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r173", "r174", "r207", "r418", "r419", "r529" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk By Benchmark [Axis]", "terseLabel": "Revenue, Net [Member]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r173", "r174", "r207", "r418", "r419", "r529" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk By Type [Axis]", "terseLabel": "Concentration Risk Type" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r173", "r174", "r207", "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk Percentage1", "terseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r173", "r174", "r207", "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r123", "r391" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation Policy [Text Block]", "terseLabel": "Principles of consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleDebt": { "auth_ref": [ "r22", "r480", "r498" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.", "label": "Convertible Debt", "terseLabel": "Convertible debt, carrying value" } } }, "localname": "ConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10200.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Convertible Debt Current", "terseLabel": "Convertible debentures, net of discount" } } }, "localname": "ConvertibleDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt [Member]" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r60" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10120.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Long Term Notes Payable", "terseLabel": "Convertible notes payable", "totalLabel": "Convertible notes payable, Non Current" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r22", "r480", "r497", "r530" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable", "terseLabel": "Convertible notes payable, carrying amount" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r54" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10210.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable Current", "terseLabel": "Convertible notes payable, net of discount" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r20", "r478", "r495", "r530" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable [Member]", "terseLabel": "Convertible Notes Payable [Member]" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r97", "r127", "r221", "r421" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10240.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost Of Revenue", "terseLabel": "COST OF GOODS SOLD" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r128", "r365", "r376" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails": { "order": 10010.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense Benefit", "terseLabel": "Current U.S." } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r132", "r365" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails": { "order": 10020.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense Benefit", "terseLabel": "International" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense Benefit Continuing Operations [Abstract]", "terseLabel": "Current" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r172", "r207" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r119", "r120" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion Converted Instrument Amount1", "terseLabel": "Conversion of convertible notes and notes payable to common stock" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "NOTES PAYABLE" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLE" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r20", "r21", "r22", "r478", "r480", "r495" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument", "verboseLabel": "Amended and Restated 10% Senior Secured Debentures [Member]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITTables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument Basis Spread On Variable Rate1", "terseLabel": "Debt instrument variable annual rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCallDateEarliest": { "auth_ref": [ "r22", "r264", "r492" ], "lang": { "en-us": { "role": { "documentation": "Earliest date before maturity when the issuer can call the outstanding debt instrument for repayment or conversion to equity, in CCYY-MM-DD format.", "label": "Debt Instrument Call Date Earliest", "terseLabel": "Call option agreement date" } } }, "localname": "DebtInstrumentCallDateEarliest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r22", "r256", "r480", "r495" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Debt Instrument Carrying Amount", "positiveLabel": "Convertible notes principal amount", "totalLabel": "Carrying Amount", "verboseLabel": "Principal Amount Outstanding" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument Convertible Conversion Price1", "positiveLabel": "Conversion Rate (in dollars per share)", "terseLabel": "Conversion price", "verboseLabel": "Conversion Price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments": { "auth_ref": [ "r58", "r264", "r265", "r267" ], "lang": { "en-us": { "role": { "documentation": "The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.", "label": "Debt Instrument Convertible Number Of Equity Instruments", "terseLabel": "Shares Underlying Notes", "verboseLabel": "Shares Underlying Notes" } } }, "localname": "DebtInstrumentConvertibleNumberOfEquityInstruments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r438", "r441" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument Face Amount", "terseLabel": "Principal amount", "verboseLabel": "Convertible notes aggregate purchase price" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": { "auth_ref": [ "r60", "r491" ], "lang": { "en-us": { "role": { "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).", "label": "Debt Instrument Frequency Of Periodic Payment", "terseLabel": "Debt instrument, frequency of periodic payment" } } }, "localname": "DebtInstrumentFrequencyOfPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r56", "r259", "r438" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument Interest Rate Effective Percentage", "positiveLabel": "Interest Rate", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument Interest Rate Stated Percentage", "positiveLabel": "Interest rate", "positiveVerboseLabel": "Percentage of monthly payments interest rate", "terseLabel": "Secured debt percentage", "verboseLabel": "Debt instrument annual interest" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentIssuanceDate1": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Date the debt instrument was issued, in CCYY-MM-DD format.", "label": "Debt Instrument Issuance Date1", "terseLabel": "Date of Loan", "verboseLabel": "Debt instrument effective date" } } }, "localname": "DebtInstrumentIssuanceDate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r57", "r406" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.", "label": "Debt Instrument Maturity Date", "terseLabel": "Debt instrument, maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument Name [Domain]", "terseLabel": "Debt Instrument, Name" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITTables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPaymentInterest": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments applied to interest.", "label": "Debt Instrument Periodic Payment Interest", "terseLabel": "Amount of Interest Paid" } } }, "localname": "DebtInstrumentPeriodicPaymentInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments applied to principal.", "label": "Debt Instrument Periodic Payment Principal", "verboseLabel": "Amount of Principal Repaid or Converted into Stock" } } }, "localname": "DebtInstrumentPeriodicPaymentPrincipal", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r60", "r131", "r264", "r266", "r267", "r268", "r437", "r438", "r441", "r493" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]", "terseLabel": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument Term", "terseLabel": "Term of Loans", "verboseLabel": "Term of Notes" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": { "auth_ref": [ "r437", "r441" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails": { "order": 10040.0, "parentTag": "us-gaap_NotesPayableCurrent", "weight": -1.0 }, "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1": { "order": 10020.0, "parentTag": "emma_ConvertibleDebenturesCurrent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.", "label": "Debt Instrument Unamortized Discount Current", "terseLabel": "Discount Amount Current" } } }, "localname": "DebtInstrumentUnamortizedDiscountCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent": { "auth_ref": [ "r437", "r441" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails": { "order": 10020.0, "parentTag": "us-gaap_LongTermNotesPayable", "weight": -1.0 }, "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2": { "order": 10020.0, "parentTag": "us-gaap_ConvertibleLongTermNotesPayable", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of debt discount to be amortized after one year or the normal operating cycle, if longer.", "label": "Debt Instrument Unamortized Discount Noncurrent", "terseLabel": "Discount Amount Non Current" } } }, "localname": "DebtInstrumentUnamortizedDiscountNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": { "auth_ref": [ "r437", "r438", "r439", "r440", "r441" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails": { "order": 10060.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount (premium).", "label": "Debt Instrument Unamortized Discount Premium Net", "terseLabel": "Discount Amount" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10210.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities Available For Sale Unrealized Gain Loss", "negatedLabel": "Tax benefit recognized on unrealized gain on debt securities" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "Debt Weighted Average Interest Rate", "terseLabel": "Average stated interest rate" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r128", "r366", "r376" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails": { "order": 10030.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense Benefit", "terseLabel": "Deferred U.S." } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r128", "r366", "r376" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails": { "order": 10040.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense Benefit", "terseLabel": "International" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense Benefit Continuing Operations [Abstract]", "terseLabel": "Deferred" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r24", "r25", "r355", "r479", "r494" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Income Tax Liabilities", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards": { "auth_ref": [ "r363", "r364" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1": { "order": 10060.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards.", "label": "Deferred Tax Assets Charitable Contribution Carryforwards", "terseLabel": "Charitable contribution" } } }, "localname": "DeferredTaxAssetsCharitableContributionCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r356" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1": { "order": 10010.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets Gross", "totalLabel": "Total gross deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r358" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets Net", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets Net [Abstract]", "terseLabel": "Components of net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r363", "r364" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1": { "order": 10030.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforward" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r363", "r364" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1": { "order": 10110.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness": { "auth_ref": [ "r361", "r363", "r364" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1": { "order": 10040.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible general business tax credit carryforwards.", "label": "Deferred Tax Assets Tax Credit Carryforwards General Business", "terseLabel": "General business tax credit" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r363", "r364" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1": { "order": 10050.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost", "terseLabel": "Stock options" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "auth_ref": [ "r363", "r364" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1": { "order": 10070.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.", "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": { "auth_ref": [ "r363", "r364" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1": { "order": 10090.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.", "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts", "terseLabel": "Allowance for bad AR" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r357" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1": { "order": 10020.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets Valuation Allowance", "negatedLabel": "Less valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r363", "r364" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails2": { "order": 10030.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities Other", "negatedLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities": { "auth_ref": [ "r363", "r364" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails2": { "order": 10020.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on trading securities.", "label": "Deferred Tax Liabilities Unrealized Gains On Trading Securities", "negatedLabel": "Unrealized gain on available-for-sale securities" } } }, "localname": "DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r293", "r295", "r296", "r298", "r299", "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan Contributions By Employer", "terseLabel": "Company matching contributions to 401(k) plans" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDEFINEDCONTRIBUTIONPLANDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Contribution Plan Disclosure [Line Items]", "terseLabel": "Defined Contribution Plan Disclosure [Line Items]" } } }, "localname": "DefinedContributionPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDEFINEDCONTRIBUTIONPLANDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.", "label": "Defined Contribution Plan Employer Matching Contribution Percent", "terseLabel": "Participant\u2019s annual compensation percentage" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDEFINEDCONTRIBUTIONPLANDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage employer matches of the employee's percentage contribution matched.", "label": "Defined Contribution Plan Employer Matching Contribution Percent Of Match", "terseLabel": "Company matching percentage of employee contributions" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDEFINEDCONTRIBUTIONPLANDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.", "label": "Defined Contribution Plan Maximum Annual Contributions Per Employee Percent", "terseLabel": "Maximum eligible annual compensation percent" } } }, "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDEFINEDCONTRIBUTIONPLANDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanTable": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.", "label": "Defined Contribution Plan [Table]", "terseLabel": "Defined Contribution Plan [Table]" } } }, "localname": "DefinedContributionPlanTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDEFINEDCONTRIBUTIONPLANDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedContributionPlanTextBlock": { "auth_ref": [ "r301", "r302" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for defined contribution plan.", "label": "Defined Contribution Plan [Text Block]", "terseLabel": "DEFINED CONTRIBUTION PLAN" } } }, "localname": "DefinedContributionPlanTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDEFINEDCONTRIBUTIONPLAN" ], "xbrltype": "textBlockItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r114", "r242" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expenses" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r114", "r184" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10160.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation Depletion And Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsAndHedgesLiabilities": { "auth_ref": [ "r54" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10170.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum as of the balance sheet date of the (a) fair values of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and (b) the carrying amounts of the liabilities arising from financial instruments or contracts used to mitigate a specified risk (hedge), and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements.", "label": "Derivative Instruments And Hedges Liabilities", "terseLabel": "Warrant derivative liabilities" } } }, "localname": "DerivativeInstrumentsAndHedgesLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation Of Revenue [Line Items]", "terseLabel": "Disaggregation Of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r283", "r285", "r286", "r287", "r288", "r289", "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation Of Revenue [Table]", "terseLabel": "Disaggregation Of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation Of Revenue Table [Text Block]", "terseLabel": "Summary of revenues by category" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Country [Member]", "terseLabel": "Federal" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r47", "r133", "r456" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails": { "order": 10070.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due To Related Parties Current", "terseLabel": "Due to EJ Holdings" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share Basic And Diluted", "verboseLabel": "EARNINGS (LOSS) PER COMMON SHARE - BASIC and DILUTED" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r123", "r162", "r163" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share Policy [Text Block]", "terseLabel": "Earnings (loss) per share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r426" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10040.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations", "terseLabel": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r349", "r377" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate", "terseLabel": "Statutory federal tax rate (in percent)" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet": { "auth_ref": [ "r401" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10280.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10110.0, "parentTag": "emma_NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.", "label": "Embedded Derivative Gain Loss On Embedded Derivative Net", "negatedLabel": "Change in fair value of embedded conversion option", "terseLabel": "Change in fair value of embedded conversion option" } } }, "localname": "EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1", "terseLabel": "Period remaining for recognition of unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r331" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options", "terseLabel": "Total unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EntityWideRevenueMajorCustomerLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Wide Revenue Major Customer [Line Items]", "terseLabel": "Entity Wide Revenue Major Customer [Line Items]" } } }, "localname": "EntityWideRevenueMajorCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]", "terseLabel": "Equipment [Member]" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r142", "r143", "r144", "r147", "r154", "r156", "r165", "r227", "r263", "r269", "r337", "r338", "r339", "r371", "r372", "r427", "r428", "r429", "r430", "r431", "r433", "r519", "r520", "r521" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": { "auth_ref": [ "r0", "r127", "r221", "r421" ], "lang": { "en-us": { "role": { "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment Nonconsolidated Investee [Axis]", "terseLabel": "Equity Method Investment, Nonconsolidated Investee" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": { "auth_ref": [ "r0", "r127", "r221", "r421" ], "lang": { "en-us": { "role": { "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment Nonconsolidated Investee [Domain]", "terseLabel": "Equity Method Investment, Nonconsolidated Investee" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment Ownership Percentage", "terseLabel": "Beneficial ownership", "verboseLabel": "Equity method investment, ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentsPolicy": { "auth_ref": [ "r41", "r108", "r123", "r220", "r421" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.", "label": "Equity Method Investments Policy", "terseLabel": "Equity method investment" } } }, "localname": "EquityMethodInvestmentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Equity Method Investments [Text Block]", "terseLabel": "Schedule of Certain Unaudited Financial Information of EJ Holdings" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesFvNi": { "auth_ref": [ "r416" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities Fv Ni", "terseLabel": "Fair value recorded in investment" } } }, "localname": "EquitySecuritiesFvNi", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": { "auth_ref": [ "r217", "r508" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10120.0, "parentTag": "emma_NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities Fv Ni Realized Gain Loss", "terseLabel": "Net gain (loss) on investment in marketable securities" } } }, "localname": "EquitySecuritiesFvNiRealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": { "auth_ref": [ "r217", "r508" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities Fv Ni Unrealized Gain Loss", "negatedLabel": "Net unrealized losses on available-for-sales on marketable securities" } } }, "localname": "EquitySecuritiesFvNiUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": { "auth_ref": [ "r216" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10170.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.", "label": "Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount", "terseLabel": "Impairment loss on long-term investment", "verboseLabel": "Impairment loss for equity securities" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EuropeanUnionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Economic and political union of member states, located primarily in Europe.", "label": "European Union [Member]", "terseLabel": "EU [Member]" } } }, "localname": "EuropeanUnionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques Table [Text Block]", "terseLabel": "Schedule of fair value based upon assumptions" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSTables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r403", "r404" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value Assets Measured On Recurring Basis [Text Block]", "terseLabel": "Schedule of Fair Value of Investment in Convertible Bonds" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r411", "r412" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Fair Value By Liability Class [Axis]", "terseLabel": "Liability Class", "verboseLabel": "Liability Instrument - Warrants [Member]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r403", "r404" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.", "label": "Fair Value Liabilities Measured On Recurring Basis [Text Block]", "terseLabel": "Schedule of fair value of conversion feature liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation By Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation Calculation Roll Forward", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement Policy Policy [Text Block]", "terseLabel": "Fair value measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss": { "auth_ref": [ "r409" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss", "terseLabel": "Change in fair value included in the statement of other comprehensive income (loss)" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues": { "auth_ref": [ "r410" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues", "terseLabel": "Fair value at issuance date" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "auth_ref": [ "r407" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings", "terseLabel": "Change in fair value included in the statement of operations" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome": { "auth_ref": [ "r409" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income", "positiveTerseLabel": "Change in fair value included in the statement of comprehensive income (loss)", "terseLabel": "Change in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "auth_ref": [ "r410" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues", "terseLabel": "Fair value at issuance date" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r407" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r123", "r414", "r417" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value Of Financial Instruments Policy", "terseLabel": "Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r422", "r423", "r424", "r425" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10200.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain Loss Before Tax", "negatedLabel": "Foreign exchange adjustments" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r123", "r435" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions And Translations Policy [Text Block]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture And Fixtures [Member]", "terseLabel": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r114", "r260", "r261" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10240.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10090.0, "parentTag": "emma_NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gains Losses On Extinguishment Of Debt", "negatedLabel": "Loss on debt extinguishment", "terseLabel": "Loss on debt extinguishment" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r98" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10220.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General And Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r96", "r127", "r187", "r195", "r198", "r201", "r203", "r221", "r421" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10180.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "GROSS PROFIT" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "auth_ref": [ "r114", "r241" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.", "label": "Impairment Of Long Lived Assets To Be Disposed Of", "terseLabel": "Impairment of long lived assets" } } }, "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r123", "r240", "r246" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment Or Disposal Of Long Lived Assets Policy [Text Block]", "terseLabel": "Impairment of long-lived assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r91", "r187", "r195", "r198", "r201", "r203", "r476", "r484", "r489", "r509" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10050.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest", "totalLabel": "INCOME (LOSS) BEFORE INCOME TAXES" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r92", "r114", "r185", "r218", "r483", "r504" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10230.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10130.0, "parentTag": "emma_NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income Loss From Equity Method Investments", "negatedLabel": "Loss on equity method investment", "terseLabel": "Net loss on equity method investment" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r350", "r353", "r360", "r374", "r378", "r380", "r381", "r382" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXES" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r128", "r155", "r156", "r186", "r348", "r375", "r379", "r510" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10060.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense Benefit", "terseLabel": "INCOME TAXES (BENEFIT)", "totalLabel": "INCOME TAXES (BENEFIT)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Expense Benefit Continuing Operations Income Tax Reconciliation [Abstract]", "terseLabel": "Reconciliation of effective income tax" } } }, "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r88", "r123", "r346", "r347", "r353", "r354", "r359", "r367", "r552" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax Policy [Text Block]", "terseLabel": "Income taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r349" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3": { "order": 10030.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance", "terseLabel": "Increase (decreases) in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r349" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3": { "order": 10010.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate", "terseLabel": "Tax benefit at statutory federal rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r349" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3": { "order": 10060.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Income Tax Reconciliation Other Adjustments", "terseLabel": "Other" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": { "auth_ref": [ "r349" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3": { "order": 10040.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.", "label": "Income Tax Reconciliation Other Reconciling Items", "terseLabel": "Permanent items" } } }, "localname": "IncomeTaxReconciliationOtherReconcilingItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r349" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3": { "order": 10020.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "Income Tax Reconciliation State And Local Income Taxes", "terseLabel": "State taxes, net of federal tax benefit" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxCreditsOther": { "auth_ref": [ "r349" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3": { "order": 10050.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other tax credits.", "label": "Income Tax Reconciliation Tax Credits Other", "negatedLabel": "General business tax credit" } } }, "localname": "IncomeTaxReconciliationTaxCreditsOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r111", "r118" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r113" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10340.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase Decrease In Accounts Payable And Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r113" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10290.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase Decrease In Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredLiabilities": { "auth_ref": [ "r113" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10350.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change during the period in carrying value for all deferred liabilities due within one year or operating cycle.", "label": "Increase Decrease In Deferred Liabilities", "terseLabel": "Deferred rent" } } }, "localname": "IncreaseDecreaseInDeferredLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable": { "auth_ref": [ "r113" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10330.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.", "label": "Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable", "terseLabel": "Income tax receivable and payable" } } }, "localname": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r113" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10300.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase Decrease In Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase Decrease In Operating Capital [Abstract]", "terseLabel": "Net changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": { "auth_ref": [ "r113" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10360.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current liabilities classified as other.", "label": "Increase Decrease In Other Current Liabilities", "terseLabel": "Other current liabilities" } } }, "localname": "IncreaseDecreaseInOtherCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "auth_ref": [ "r113" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10320.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.", "label": "Increase Decrease In Other Noncurrent Assets", "negatedLabel": "Other non-current assets" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10370.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase Decrease In Other Noncurrent Liabilities", "terseLabel": "Other long-term liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r113" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10310.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase Decrease In Stockholders Equity Roll Forward", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "stringItemType" }, "us-gaap_InducedConversionOfConvertibleDebtExpense": { "auth_ref": [ "r255" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10260.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10150.0, "parentTag": "emma_NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Consideration given by issuer of convertible debt to provide an incentive for debt holders to convert the debt to equity securities. The expense is equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms.", "label": "Induced Conversion Of Convertible Debt Expense", "negatedLabel": "Notes conversion costs", "terseLabel": "Notes conversion costs" } } }, "localname": "InducedConversionOfConvertibleDebtExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndOtherIncome": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10160.0, "parentTag": "emma_NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).", "label": "Interest And Other Income", "terseLabel": "Interest and other income" } } }, "localname": "InterestAndOtherIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r90", "r183", "r436", "r439", "r488" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10170.0, "parentTag": "emma_NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r106", "r110", "r118" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid Net", "terseLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r11", "r12", "r54" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails": { "order": 10030.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable Current", "terseLabel": "Accrued interest payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r66" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails": { "order": 10030.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory Finished Goods", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r2", "r69" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10300.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory Net", "terseLabel": "Inventories, net", "totalLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r13", "r70", "r123", "r164", "r234", "r235", "r237" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory Policy [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsAndSupplies": { "auth_ref": [ "r68" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails": { "order": 10010.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.", "label": "Inventory Raw Materials And Supplies", "terseLabel": "Raw materials and components" } } }, "localname": "InventoryRawMaterialsAndSupplies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r69", "r140", "r236" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails": { "order": 10040.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedLabel": "Inventory reserve" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r67" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails": { "order": 10020.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory Work In Process", "terseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentHoldingsTextBlock": { "auth_ref": [ "r531", "r541", "r542", "r545", "r546" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investment holdings. This includes the long positions of investments for the entity. It contains investments in affiliated and unaffiliated issuers. The investments include securities and non securities (i.e. commodities and futures contracts).", "label": "Investment Holdings [Text Block]", "terseLabel": "INVESTMENTS" } } }, "localname": "InvestmentHoldingsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r543", "r544", "r547", "r548", "r549", "r550" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r543", "r544", "r547", "r548", "r549", "r550" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investment Type Categorization [Member]", "terseLabel": "Investments" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments [Abstract]" } } }, "localname": "InvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeaseExpirationDate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date which lease or group of leases is set to expire, in CCYY-MM-DD format.", "label": "Lease Expiration Date1", "terseLabel": "Operating lease, expiration date" } } }, "localname": "LeaseExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_LeaseholdsAndLeaseholdImprovementsMember": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "Assets held by a lessee under a capital lease and any addition or improvement to assets held under a lease arrangement (including addition or improvement to assets held by lessee under an operating lease arrangement).", "label": "Leaseholds And Leasehold Improvements [Member]", "terseLabel": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdsAndLeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r446" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee Leases Policy [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r450" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee Operating Lease Liability Maturity Table [Text Block]", "terseLabel": "Schedule of future minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r450" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee Operating Lease Liability Payments Due", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r450" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails": { "order": 10010.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r450" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails": { "order": 10040.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Four", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r450" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails": { "order": 10030.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Three", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r450" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails": { "order": 10020.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Two", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r450" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails2": { "order": 10010.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee Operating Lease Liability Undiscounted Excess Amount", "negatedLabel": "Less: Interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee Operating Leases [Text Block]", "terseLabel": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASES" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r52", "r127", "r197", "r221", "r390", "r395", "r396", "r421" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10010.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "LIABILITIES" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r34", "r127", "r221", "r421", "r482", "r502" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities And Stockholders Equity", "totalLabel": "Total liabilities & stockholders\u2019 deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities And Stockholders Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r55", "r127", "r221", "r390", "r395", "r396", "r421" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2": { "order": 10010.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10080.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities Current", "terseLabel": "CURRENT LIABILITIES", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities Current [Abstract]", "terseLabel": "CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r14", "r15", "r16", "r22", "r23", "r127", "r221", "r390", "r395", "r396", "r421" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2": { "order": 10020.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities Noncurrent", "verboseLabel": "LONG-TERM LIABILITIES" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r22", "r480", "r495" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line Of Credit", "terseLabel": "Line of credit outstanding balance" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility terminates, in CCYY-MM-DD format.", "label": "Line Of Credit Facility Expiration Date1", "terseLabel": "Line of credit expiration date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "The effective interest rate at the end of the reporting period.", "label": "Line Of Credit Facility Interest Rate At Period End", "terseLabel": "Line of credit effective interest rate" } } }, "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r49" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line Of Credit Facility Maximum Borrowing Capacity", "terseLabel": "Line of credit maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LinesOfCreditCurrent": { "auth_ref": [ "r20", "r478" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10160.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Lines Of Credit Current", "terseLabel": "Revolving line of credit from related party" } } }, "localname": "LinesOfCreditCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r22", "r257", "r480", "r498" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails3": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long Term Debt", "totalLabel": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtByMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Debt By Maturity [Abstract]" } } }, "localname": "LongTermDebtByMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r134", "r251" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails3": { "order": 10010.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Next Twelve Months", "terseLabel": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r134", "r251" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails3": { "order": 10030.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Three", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r134", "r251" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails3": { "order": 10020.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Two", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r60" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Long Term Notes Payable", "totalLabel": "Notes payable, non-current" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermPurchaseCommitmentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.", "label": "Long Term Purchase Commitment Amount", "terseLabel": "Purchase amount" } } }, "localname": "LongTermPurchaseCommitmentAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermPurchaseCommitmentMinimumMassRequired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mass of goods that must be purchased within the specified time period of the agreement to avoid penalties or unfavorable effects on pricing, among other adverse consequences.", "label": "Long Term Purchase Commitment Minimum Mass Required", "terseLabel": "Purchase Quantity" } } }, "localname": "LongTermPurchaseCommitmentMinimumMassRequired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative" ], "xbrltype": "massItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Longterm Debt Type [Axis]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r60", "r252" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Longterm Debt Type [Domain]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MarketableSecuritiesCurrent": { "auth_ref": [ "r4", "r53" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10310.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as current.", "label": "Marketable Securities Current", "terseLabel": "Investment in marketable securities" } } }, "localname": "MarketableSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r490" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities Policy", "terseLabel": "Marketable securities" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MeasurementInputConversionPriceMember": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using price per share at which convertible share can be converted into common stock.", "label": "Measurement Input Conversion Price [Member]", "terseLabel": "Conversion Price [Member]" } } }, "localname": "MeasurementInputConversionPriceMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExercisePriceMember": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using agreed upon price for exchange of underlying asset.", "label": "Measurement Input Exercise Price [Member]", "terseLabel": "Measurement Input, Exercise Price [Member]" } } }, "localname": "MeasurementInputExercisePriceMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input Expected Dividend Rate [Member]", "terseLabel": "Expected Dividend Yield [Member]" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input Expected Term [Member]", "terseLabel": "Expected Life (in years) [Member]", "verboseLabel": "Measurement Input, Expected Life (in Years) [Member]" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input Price Volatility [Member]", "terseLabel": "Expected Volatility (Telcon common stock) [Member]", "verboseLabel": "Measurement Input, Expected Volatility (Peer Group) [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input Risk Free Interest Rate [Member]", "terseLabel": "Risk-free Interest Rate (South Korea government bond) [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r65", "r127", "r221", "r421", "r481", "r501" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Minority Interest", "terseLabel": "NONCONTROLLING INTEREST" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r166", "r179" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature Of Operations", "terseLabel": "DESCRIPTION OF BUSINESS" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESS" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r109" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10030.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided By Used In Financing Activities", "totalLabel": "Net cash flows provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Financing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r109" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10020.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided By Used In Investing Activities", "totalLabel": "Net cash flows provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Investing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r109", "r112", "r115" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10010.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided By Used In Operating Activities", "totalLabel": "Net cash flows used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r0", "r82", "r85", "r93", "r115", "r127", "r146", "r150", "r151", "r152", "r153", "r155", "r156", "r159", "r187", "r195", "r198", "r201", "r203", "r221", "r421", "r485", "r505" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10010.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income Loss", "terseLabel": "Net income (loss)", "totalLabel": "NET INCOME (LOSS)", "verboseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements Policy Policy [Text Block]", "terseLabel": "Recent accounting pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r51" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes Payable Current", "totalLabel": "Notes payable, current" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableOtherPayablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A written promise to pay a note to a third party.", "label": "Notes Payable Other Payables [Member]", "terseLabel": "Notes Payable [Member]" } } }, "localname": "NotesPayableOtherPayablesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r46", "r133", "r457" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10190.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable Related Parties Classified Current", "terseLabel": "Notes payable to related parties" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableGross": { "auth_ref": [ "r231", "r232", "r233" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of financing receivable.", "label": "Notes Receivable Gross", "positiveVerboseLabel": "Loan receivables" } } }, "localname": "NotesReceivableGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number Of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10190.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "OPERATING EXPENSES" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r187", "r195", "r198", "r201", "r203" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10070.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income Loss", "totalLabel": "LOSS FROM OPERATIONS" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r445" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease Expense", "terseLabel": "Rent expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r444" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails2": { "order": 10020.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease Liability", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r444" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10140.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability Current", "terseLabel": "Operating lease liabilities, current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r444" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10090.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease Liability Noncurrent", "terseLabel": "Operating lease liabilities, less current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r443" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10250.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease Right Of Use Asset", "terseLabel": "Right of use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r449", "r451" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease Weighted Average Discount Rate Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r448", "r451" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease Weighted Average Remaining Lease Term1", "terseLabel": "Weighted average remaining term of leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r361" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]", "terseLabel": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r10", "r11", "r12", "r54" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails": { "order": 10080.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities Current", "terseLabel": "Other accrued expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r71" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails1": { "order": 10010.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets Current", "positiveTerseLabel": "Other prepaid expenses and current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r45" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10270.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets Noncurrent", "terseLabel": "Other assets", "verboseLabel": "OTHER ASSETS" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income Available For Sale Securities Adjustment Net Of Tax Period Increase Decrease [Abstract]", "terseLabel": "COMPONENTS OF OTHER COMPREHENSIVE INCOME (LOSS)" } } }, "localname": "OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r75" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10040.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax", "terseLabel": "Foreign currency translation adjustments", "verboseLabel": "Foreign currency translation effect" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r83", "r86", "r89", "r94", "r263", "r427", "r432", "r433", "r486", "r506" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10020.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income Loss Net Of Tax", "totalLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r76", "r78" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10030.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax", "terseLabel": "Unrealized gain on debt securities available for sale (net of tax)", "verboseLabel": "Unrealized gain on debt securities available for sale (net of tax)" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current liabilities.", "label": "Other Current Liabilities [Member]", "terseLabel": "Other Current Liabilities [Member]" } } }, "localname": "OtherCurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails4", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r9", "r10", "r54" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10150.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities Current", "terseLabel": "Other current liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r61" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10100.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other Long-Term Liabilities [Member]" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other noncurrent liabilities.", "label": "Other Noncurrent Liabilities Table [Text Block]", "terseLabel": "Schedule of other long-term liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income Expense [Abstract]", "terseLabel": "OTHER INCOME (EXPENSE)" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "stringItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables And Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r101", "r386" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10100.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments To Acquire Businesses Gross", "negatedLabel": "Cash paid in connection with the Merger" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r102" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Payments To Acquire Productive Assets", "terseLabel": "PGLG, purchase price" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r102" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10120.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments To Acquire Property Plant And Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r310", "r332" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock Par Or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock Shares Authorized", "terseLabel": "Preferred stock, authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock Shares Issued", "terseLabel": "Preferred stock, issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock Shares Outstanding", "terseLabel": "Preferred stock, outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r26" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10030.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock Value", "terseLabel": "Preferred stock \u2014 par value $0.001 per share, 15,000,000 shares authorized, none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r6", "r38", "r39" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails1": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10320.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense And Other Assets Current", "terseLabel": "Prepaid expenses and other current assets", "totalLabel": "Total" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepaid Expense And Other Assets Current [Abstract]" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PrepaidInsurance": { "auth_ref": [ "r5", "r7", "r238", "r239" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails1": { "order": 10020.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Insurance", "terseLabel": "Prepaid insurance" } } }, "localname": "PrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]", "terseLabel": "Prime Rate" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r104" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds From Convertible Debt", "terseLabel": "Proceeds from convertible notes payable issued, net of issuance cost and discount", "verboseLabel": "Net proceeds from the sale of the convertible promissory notes" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r103" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10090.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds From Issuance Of Common Stock", "terseLabel": "Proceeds from issuance of common stock, net of issuance cost" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r104" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10050.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds From Notes Payable", "terseLabel": "Proceeds from notes payable issued, net of issuance cost and discount" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10110.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds From Sale And Maturity Of Marketable Securities", "verboseLabel": "Sale of marketable securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfNotesReceivable": { "auth_ref": [ "r100" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale of a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds From Sale Of Notes Receivable", "terseLabel": "Proceeds from sale of convertible notes" } } }, "localname": "ProceedsFromSaleOfNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r103" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10080.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds From Warrant Exercises", "terseLabel": "Proceeds from exercise of warrants" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductAndServiceOtherMember": { "auth_ref": [ "r285" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.", "label": "Product And Service Other [Member]", "terseLabel": "Other [Member]" } } }, "localname": "ProductAndServiceOtherMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r0", "r82", "r85", "r107", "r127", "r146", "r155", "r156", "r187", "r195", "r198", "r201", "r203", "r221", "r388", "r392", "r393", "r397", "r398", "r421", "r489" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10150.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Profit Loss", "positiveVerboseLabel": "NET LOSS", "terseLabel": "Net Income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property Plant And Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r44", "r245" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property Plant And Equipment By Type [Axis]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r43", "r243" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails2": { "order": 10010.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Gross", "terseLabel": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property Plant And Equipment [Line Items]", "terseLabel": "Property and equipment" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r18", "r19", "r245", "r503" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails2": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10230.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Net", "terseLabel": "Property and equipment, net", "totalLabel": "Property and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r42", "r123", "r245", "r553", "r554" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property Plant And Equipment Policy [Text Block]", "terseLabel": "Property and equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r18", "r245" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property Plant And Equipment [Text Block]", "terseLabel": "Schedule of property and equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r18", "r243" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property Plant And Equipment Type [Domain]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property Plant And Equipment Useful Life", "terseLabel": "Useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ReceivableTypeDomain": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.", "label": "Receivable Type [Domain]", "terseLabel": "Receivable" } } }, "localname": "ReceivableTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r123", "r211", "r213", "r214", "r215" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Receivables Policy [Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r453", "r454", "r456", "r460", "r461" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONS" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfConvertibleDebt": { "auth_ref": [ "r105" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10070.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Repayments Of Convertible Debt", "negatedLabel": "Payments of convertible notes" } } }, "localname": "RepaymentsOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r105" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10060.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments Of Notes Payable", "negatedLabel": "Payments of notes payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r344", "r565" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10200.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research And Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r123", "r344" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research And Development Expense Policy", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r30", "r269", "r340", "r500", "r523", "r528" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10070.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings Accumulated Deficit", "terseLabel": "Accumulated deficit", "verboseLabel": "Cumulative-effect increase on our accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r142", "r143", "r144", "r147", "r154", "r156", "r227", "r337", "r338", "r339", "r371", "r372", "r519", "r521" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue From Contract With Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r181", "r182", "r194", "r199", "r200", "r204", "r205", "r207", "r282", "r283", "r472" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10230.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue From Contract With Customer Excluding Assessed Tax", "positiveLabel": "Revenue from contract", "terseLabel": "REVENUES, NET", "verboseLabel": "Revenues, net" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r284", "r292" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue From Contract With Customer [Text Block]", "terseLabel": "REVENUES" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUES" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuePerformanceObligationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue Performance Obligation [Abstract]" } } }, "localname": "RevenuePerformanceObligationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r124", "r125" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition Policy [Text Block]", "terseLabel": "Revenue recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]", "terseLabel": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table]", "terseLabel": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Line of Credit Facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r447", "r451" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right Of Use Asset Obtained In Exchange For Operating Lease Liability", "terseLabel": "Initial recognition of right-of-use lease asset" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r173", "r207" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Sales Revenue Net [Member]", "terseLabel": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule Of Accounts Payable And Accrued Liabilities Table [Text Block]", "terseLabel": "Schedule of accounts payable and accrued expenses" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]", "terseLabel": "Schedule of provision for income taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule Of Debt Table [Text Block]", "terseLabel": "Schedule of notes payable" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]", "terseLabel": "Schedule of deferred tax assets and liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]", "terseLabel": "Schedule of income tax provision computed using the statutory federal tax rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": { "auth_ref": [ "r207" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.", "label": "Schedule Of Entity Wide Revenue By Major Customers By Reporting Segments [Table]", "terseLabel": "Schedule Of Entity Wide Revenue By Major Customers By Reporting Segments [Table]" } } }, "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r13", "r35", "r36", "r37" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule Of Inventory Current Table [Text Block]", "terseLabel": "Schedule of inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule Of Investments [Line Items]", "terseLabel": "Schedule Of Investments [Line Items]" } } }, "localname": "ScheduleOfInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsTable": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.", "label": "Schedule Of Investments [Table]", "terseLabel": "Schedule Of Investments [Table]" } } }, "localname": "ScheduleOfInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails2", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfOtherAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Schedule Of Other Assets Table [Text Block]", "terseLabel": "Schedule of prepaid expenses and other current assets" } } }, "localname": "ScheduleOfOtherAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r44", "r245" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule Of Property Plant And Equipment [Table]", "terseLabel": "Schedule Of Property Plant And Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETSDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r129", "r457", "r459" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule Of Related Party Transactions By Related Party [Table]", "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.", "label": "Schedule Of Related Party Transactions Table [Text Block]", "terseLabel": "Schedule of outstanding loans from related parties" } } }, "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r316", "r323", "r324" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]", "terseLabel": "Summary of stock option activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r326" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]", "terseLabel": "Schedule of valuation assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule Of Short Term Debt [Table]", "terseLabel": "Schedule Of Short Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r272", "r308" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block]", "terseLabel": "Summary of outstanding warrants" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSubsequentEventsTextBlock": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, losses resulting from fire or flood, losses on receivables, significant realized and unrealized gains and losses that result from changes in quoted market prices of securities, declines in market prices of inventory, changes in authorized or issued debt (SEC), significant foreign exchange rate changes, substantial loans to insiders or affiliates, significant long-term investments, and substantial dividends not in the ordinary course of business.", "label": "Schedule Of Subsequent Events [Text Block]", "terseLabel": "Schedule of subsequent events" } } }, "localname": "ScheduleOfSubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r171", "r173", "r174", "r175", "r418", "r420" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Schedules Of Concentration Of Risk By Risk Factor [Text Block]", "terseLabel": "Summarizes revenues from customers accounted for 10% or more of net revenues and account receivables" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r123", "r188", "r189", "r190", "r191", "r192", "r193", "r205" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting Policy Policy [Text Block]", "terseLabel": "Segment reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 10210.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling And Marketing Expense", "terseLabel": "Selling" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r113" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share Based Compensation", "terseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [ "r325" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms", "terseLabel": "Weighted Average Remaining Contractual Life (Years), Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails5" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price", "terseLabel": "Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate", "terseLabel": "Dividend Yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate", "terseLabel": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum", "terseLabel": "Volatility, Maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum", "terseLabel": "Volatility, Minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate", "terseLabel": "Risk-Free Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum", "terseLabel": "Risk-Free Rate, Maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum", "terseLabel": "Risk-Free Rate, Minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized", "terseLabel": "Number of shares authorized under the plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant", "terseLabel": "Number of Options, Options available for future grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number", "terseLabel": "Number of Options, Options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price", "terseLabel": "Weighted-Average Exercise Price, Options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period", "negatedLabel": "Number of Options, Cancelled, forfeited and expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period", "terseLabel": "Stock options granted options to purchase common stock" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross", "verboseLabel": "Number of Options, Granted or deemed granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r318", "r332" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number", "periodEndLabel": "Number of Options outstanding, end", "periodStartLabel": "Number of Options outstanding, beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price", "periodEndLabel": "Weighted-Average Exercise Price, Options outstanding, end", "periodStartLabel": "Weighted-Average Exercise Price, Options outstanding, beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r308", "r314" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]", "terseLabel": "Award Type" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price", "terseLabel": "Weighted-Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price", "terseLabel": "Weighted-Average Exercise Price, Cancelled, forfeited and expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price", "terseLabel": "Exercise price - options", "verboseLabel": "Weighted-Average Exercise Price, Granted or deemed granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share Based Compensation Award Tranche One [Member]", "terseLabel": "Share Based Compensation Award, Tranche One [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheOneMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share Based Compensation Award Tranche Two [Member]", "terseLabel": "Share Based Compensation Award, Tranche Two [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheTwoMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Stock price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage", "terseLabel": "Vesting percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period", "terseLabel": "Expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r327", "r341" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1", "terseLabel": "Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails6" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares Outstanding", "periodEndLabel": "Balance, ending (in shares)", "periodStartLabel": "Balance, beginning (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short Term Debt [Line Items]", "terseLabel": "Short-term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureRELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State And Local Jurisdiction [Member]", "terseLabel": "State and Local" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r63", "r142", "r143", "r144", "r147", "r154", "r156", "r165", "r227", "r263", "r269", "r337", "r338", "r339", "r371", "r372", "r427", "r428", "r429", "r430", "r431", "r433", "r519", "r520", "r521" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]", "terseLabel": "Common Stock [Member]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITTables", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Stockholders Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r142", "r143", "r144", "r165", "r472" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLETables", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITTables", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r26", "r27", "r269" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period Shares Acquisitions", "terseLabel": "Common stock issued in merger ( in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r62", "r263", "r264", "r269" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period Shares Conversion Of Convertible Securities", "terseLabel": "Conversion of convertible notes payable and notes payable to common stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r26", "r27", "r263", "r269" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period Shares New Issues", "positiveLabel": "Common stock shares issued for consideration", "terseLabel": "Common stock issued for cash (net of issuance cost) (in shares)", "verboseLabel": "Number of Shares Issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r26", "r27", "r263", "r269", "r321" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock Issued During Period Shares Stock Options Exercised", "negatedLabel": "Number of Options, Exercised", "terseLabel": "Exercise of stock options (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails7", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "auth_ref": [ "r26", "r27", "r263", "r269" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of a stock split.", "label": "Stock Issued During Period Shares Stock Splits", "terseLabel": "Common stock shares, stock split ratio" } } }, "localname": "StockIssuedDuringPeriodSharesStockSplits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r26", "r27", "r263", "r269" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period Value New Issues", "positiveLabel": "Addition to equity for common stock", "terseLabel": "Common stock issued for cash (net of issuance cost)", "verboseLabel": "Common shares" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r63", "r263", "r269" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period Value Stock Options Exercised", "terseLabel": "Exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Stock Option [Member]", "terseLabel": "Stock Options [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r27", "r32", "r33", "r127", "r212", "r221", "r421" ], "calculation": { "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10020.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders Equity", "periodEndLabel": "Balance, ending", "periodStartLabel": "Balance, beginning", "totalLabel": "Total stockholders\u2019 deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders Equity [Abstract]", "terseLabel": "STOCKHOLDERS\u2019 DEFICIT" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r126", "r269", "r273" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS' DEFICIT" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICIT" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.", "label": "Stockholders Equity Note Stock Split Conversion Ratio1", "terseLabel": "Reverse split, conversion ratio" } } }, "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative" ], "xbrltype": "pureItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Stockholders Equity Reverse Stock Split", "terseLabel": "Reverse split" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureDESCRIPTIONOFBUSINESSDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r434", "r463" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r434", "r463" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r434", "r463" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r434", "r463" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetails", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r462", "r464" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSASSETS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "SUPPLEMENTAL DISCLOSURES OF CASH FLOW ACTIVITIES" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [ "r361" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Tax Credit Carryforward Amount", "terseLabel": "General business tax credits" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeReceivablesHeldForSaleAmount": { "auth_ref": [ "r209" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before valuation allowance, of accounts receivable held for sale.", "label": "Trade Receivables Held For Sale Amount", "terseLabel": "Accounts receivable face amount" } } }, "localname": "TradeReceivablesHeldForSaleAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r146", "r147", "r148", "r149", "r224", "r225", "r226", "r227", "r229", "r230", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r369", "r370", "r371", "r372", "r473", "r474", "r475", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Type Of Adoption [Member]", "terseLabel": "Accounting Standards Update" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureLEASESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICIT" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Type Of Arrangement [Axis]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureREVENUESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUBSEQUENTEVENTSDetailsNarrative", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r345", "r352" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredLongTermDebt": { "auth_ref": [ "r60" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Unsecured Long Term Debt", "terseLabel": "Unsecured debt" } } }, "localname": "UnsecuredLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by nature of risk and uncertainty, for example, but not limited to, threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.", "label": "Unusual Risk Or Uncertainty By Nature [Axis]", "terseLabel": "Unusual Risk or Uncertainty, Nature" } } }, "localname": "UnusualRiskOrUncertaintyByNatureAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualRiskOrUncertaintyNatureDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Describes the nature of the unusual risk or uncertainty, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.", "label": "Unusual Risk Or Uncertainty Nature [Domain]", "terseLabel": "Unusual Risk or Uncertainty, Nature" } } }, "localname": "UnusualRiskOrUncertaintyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r167", "r168", "r169", "r170", "r176", "r177", "r178" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use Of Estimates", "terseLabel": "Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r358" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance Deferred Tax Asset Change In Amount", "terseLabel": "Valuation allowance increased (decreased)" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINCOMETAXESDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [ "r135", "r136", "r137", "r138", "r139" ], "lang": { "en-us": { "role": { "documentation": "Valuation and qualifying accounts and reserves.", "label": "Valuation Allowances And Reserves [Domain]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves" } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r135", "r136", "r137", "r138", "r139" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "Valuation Allowances And Reserves Type [Axis]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSELECTEDFINANCIALSTATEMENTCAPTIONSLIABILITIESDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationTechniqueAxis": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation approach and technique.", "label": "Valuation Technique [Axis]", "terseLabel": "Valuation Approach and Technique" } } }, "localname": "ValuationTechniqueAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationTechniqueDomain": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach and technique.", "label": "Valuation Technique [Domain]", "terseLabel": "Valuation Approach and Technique" } } }, "localname": "ValuationTechniqueDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureINVESTMENTSDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5" ], "xbrltype": "domainItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]", "terseLabel": "Vesting" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]", "terseLabel": "Vesting" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails4" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants And Rights Outstanding Measurement Input", "terseLabel": "Selected yield", "verboseLabel": "Warrants and rights outstanding, measurement input" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3" ], "xbrltype": "decimalItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants And Rights Outstanding Term", "terseLabel": "Expected life (in years)" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureNOTESPAYABLEDetails5", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails1", "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSTOCKHOLDERSDEFICITDetails3" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted Average Number Diluted Shares Outstanding Adjustment", "terseLabel": "Potentially dilutive securities outstanding" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r158", "r161" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number Of Shares Outstanding Basic", "terseLabel": "WEIGHTED AVERAGE COMMON SHARES OUTSTANDING" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.emmausmedical.com/20201231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "sharesItemType" } }, "unitCount": 13 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04.(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r141": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31010-122693" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r179": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117546-209714" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL82887624-210437" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "79", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82922352-210448" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "80", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82922355-210448" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r237": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2611-110228" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r249": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=51819886&loc=SL6014347-161799" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "40", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120517889&loc=d3e6835-112609" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629" }, "r262": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.C)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r273": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r292": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r302": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/subtopic&trid=2235116" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "51", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e34017-109320" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r382": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r401": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "15", "Topic": "815", "URI": "http://asc.fasb.org/subtopic&trid=2229187" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117332851&loc=SL7495116-110257" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117817908&loc=SL117819236-161440" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r435": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28567-108399" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r452": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r461": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r464": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62652-112803" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(e)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(d))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.2)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611133-123010" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611322-123010" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r566": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r567": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r568": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r569": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r571": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "303", "Subparagraph": "(5)" }, "r572": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r573": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r574": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r575": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r576": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4),(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r74": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "http://asc.fasb.org/topic&trid=2122208" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" } }, "version": "2.1" }